99300-78-4 | 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol hydrochloride

Packsize	Purity	Availability	Price	Discounted Price
1g	98%	in stock	$26.00	$18.00
5g	98%	in stock	$34.00	$24.00
25g	98%	in stock	$74.00	$52.00
100g	98%	in stock	$203.00	$142.00
500g	98%	in stock	$573.00	$402.00

Description

• Catalog Number: AB80330
• Chemical Name: 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol hydrochloride
• CAS Number: 99300-78-4
• Molecular Formula: C17H28ClNO2
• Molecular Weight: 313.8627
• MDL Number: MFCD03658865
• SMILES: COc1ccc(cc1)C(C1(O)CCCCC1)CN(C)C.Cl
• NSC Number: 745751

Computed Properties

• Complexity: 279
• Covalently-Bonded Unit Count: 2
• Heavy Atom Count: 21
• Hydrogen Bond Acceptor Count: 3
• Hydrogen Bond Donor Count: 2
• Rotatable Bond Count: 5
• Undefined Atom Stereocenter Count: 1

Literature

• Venlafaxine mitigates cisplatin-induced nephrotoxicity via down-regulating apoptotic pathway in rats.

  Chemico-biological interactions 20180625

• Steroidogenic disruptive effects of the serotonin-noradrenaline reuptake inhibitors duloxetine, venlafaxine and tramadol in the H295R cell assay and in a recombinant CYP17 assay.

  Toxicology in vitro : an international journal published in association with BIBRA 20180301

• Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.

  Chemical research in toxicology 20150518

• Transcriptional evidence for the role of chronic venlafaxine treatment in neurotrophic signaling and neuroplasticity including also Glutamatergic [corrected] - and insulin-mediated neuronal processes.

  PloS one 20140101

• Antidepressants inhibit DNA methyltransferase 1 through reducing G9a levels.

  The Biochemical journal 20121115

• Chronic social defeat stress model: behavioral features, antidepressant action, and interaction with biological risk factors.

  Psychopharmacology 20121101

• Venlafaxine-induced cholestatic hepatitis: case report and review of literature.

  The American journal of surgical pathology 20121101

• Chronic serotonin-norepinephrine reuptake transporter inhibition modifies basal respiratory output in adult mouse in vitro and in vivo.

  Respiratory physiology & neurobiology 20121015

• Does prior antidepressant treatment of major depression impact brain function during current treatment?

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20121001

• The modulation of venlafaxine on cortical activation of language area in healthy subjects with fMRI study.

  Psychopharmacology 20121001

• Patterns of cardiorespiratory coordination in young women with recurrent major depressive disorder treated with escitalopram or venlafaxine.

  Progress in neuro-psychopharmacology & biological psychiatry 20121001

• A venlafaxine and mirtazapine-induced serotonin syndrome confirmed by de- and re-challenge.

  International journal of clinical pharmacy 20121001

• Duodenal calcium transporter mRNA expression in stressed male rats treated with diazepam, fluoxetine, reboxetine, or venlafaxine.

  Molecular and cellular biochemistry 20121001

• Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response.

  Molecular psychiatry 20120901

• The effect of age, sex, smoking and co-medication on serum levels of venlafaxine and O-desmethylvenlafaxine under naturalistic conditions.

  Pharmacopsychiatry 20120901

• An indirect comparison of the efficacy and safety of desvenlafaxine and venlafaxine using placebo as the common comparator.

  CNS spectrums 20120901

• Bilateral pallidal necrosis and cardiac toxicity in a patient with venlafaxine and bupropion overdose.

  The American journal of psychiatry 20120901

• Differential effects of fluoxetine and venlafaxine on memory recognition: possible mechanisms of action.

  Progress in neuro-psychopharmacology & biological psychiatry 20120807

• Endpoints of drug discovery for menopausal vasomotor symptoms: interpretation of data from a proxy of disease.

  Menopause (New York, N.Y.) 20120801

• Bioavailability of pharmaceuticals in waters close to wastewater treatment plants: use of fish bile for exposure assessment.

  Environmental toxicology and chemistry 20120801

• Agomelatine versus venlafaxine XR in the treatment of anhedonia in major depressive disorder: a pilot study.

  Journal of clinical psychopharmacology 20120801

• Platelet count alterations associated with escitalopram, venlafaxine and bupropion in depressive patients.

  Psychiatry and clinical neurosciences 20120801

• The effects of serotonin/norepinephrine reuptake inhibitors and serotonin receptor agonist on morphine analgesia and tolerance in rats.

  The journal of physiological sciences : JPS 20120701

• The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.

  The Journal of clinical psychiatry 20120701

• Long-lasting effects of chronic rTMS to treat chronic rodent model of depression.

  Behavioural brain research 20120615

• Molecular adaptation to chronic antidepressant treatment: evidence for a more rapid response to the novel α₂-adrenoceptor antagonist/5-HT-noradrenaline reuptake inhibitor (SNRI), S35966, compared to the SNRI, venlafaxine.

  The international journal of neuropsychopharmacology 20120601

• A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder.

  The international journal of neuropsychopharmacology 20120601

• Resilience as a predictor of treatment response in patients with posttraumatic stress disorder treated with venlafaxine extended release or placebo.

  Journal of psychopharmacology (Oxford, England) 20120601

• Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine.

  Archives of general psychiatry 20120601

• Field and laboratory studies of the fate and enantiomeric enrichment of venlafaxine and O-desmethylvenlafaxine under aerobic and anaerobic conditions.

  Chemosphere 20120601

• A short-term double-blind randomized controlled pilot trial with active or placebo pindolol in patients treated with venlafaxine for major depression.

  Nordic journal of psychiatry 20120601

• Recovery and subsequent recurrence in patients with recurrent major depressive disorder.

  Journal of psychiatric research 20120601

• Venlafaxine enhances the effect of bupropion on extracellular dopamine in rat frontal cortex.

  Canadian journal of physiology and pharmacology 20120601

• Implication of free cholesterol in LC-MS response enhancement.

  Bioanalysis 20120601

• [Diagnostic and therapeutic update in narcolepsy].

  Revista de neurologia 20120521

• Anxiolytic-like actions of reboxetine, venlafaxine and endurance swimming in stressed male rats.

  Behavioural brain research 20120516

• Fatal agranulocytosis associated with psychotropic medication use.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20120515

• The analysis of binary longitudinal data with time-dependent covariates.

  Statistics in medicine 20120510

• Antidepressant-like effect of the ethanolic extract from Suanzaorenhehuan Formula in mice models of depression.

  Journal of ethnopharmacology 20120507

• Efficacy, safety, and tolerability of a triple reuptake inhibitor GSK372475 in the treatment of patients with major depressive disorder: two randomized, placebo- and active-controlled clinical trials.

  Journal of psychopharmacology (Oxford, England) 20120501

• Venlafaxin-associated post-ictal asystole during electroconvulsive therapy.

  Pharmacopsychiatry 20120501

• Lack of a pharmacokinetic drug-drug interaction with venlafaxine extended-release/indinavir and desvenlafaxine extended-release/indinavir.

  European journal of clinical pharmacology 20120501

• Adjunctive therapy with pregabalin in generalized anxiety disorder patients with partial response to SSRI or SNRI treatment.

  International clinical psychopharmacology 20120501

• Optimized light therapy for non-seasonal major depressive disorder: effects of timing and season.

  Journal of affective disorders 20120501

• Impact of wastewater treatment plant discharge of lidocaine, tramadol, venlafaxine and their metabolites on the quality of surface waters and groundwater.

  Journal of environmental monitoring : JEM 20120501

• [A case of venlafaxine-induced syndrome of inappropriate ADH secretion (SIADH) - treatment with tolvaptan].

  Deutsche medizinische Wochenschrift (1946) 20120501

• Switching to sertraline or venlafaxine after failure of SSRIs treatment in major depressive disorder: an economic evaluation of the STAR*D trial.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20120501

• Venlafaxine facilitates between-session extinction and prevents reinstatement of auditory-cue conditioned fear.

  Behavioural brain research 20120421

• Glad about SAD (PD).

  Neurology 20120417

• A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease.

  Neurology 20120417

• Preparation and in vitro/in vivo evaluation of sustained-release venlafaxine hydrochloride pellets.

  International journal of pharmaceutics 20120415

• Long lasting effects of early-life stress on glutamatergic/GABAergic circuitry in the rat hippocampus.

  Neuropharmacology 20120401

• Occurrence of Tako-Tsubo cardiomyopathy in association with ingestion of serotonin/noradrenaline reuptake inhibitors.

  Heart, lung & circulation 20120401

• Selective serotonin reuptake inhibitors, venlafaxine and duloxetine are associated with in hospital morbidity but not bleeding or late mortality after coronary artery bypass graft surgery.

  Heart, lung & circulation 20120401

• Anti-depressant effects of Xiaoyaosan on rat model of chronic unpredictable mild stress: a plasma metabonomics study based on NMR spectroscopy.

  The Journal of pharmacy and pharmacology 20120401

• A case of primary progressive aphasia associated with depression.

  International journal of geriatric psychiatry 20120401

• Comparison of monoamine reuptake inhibitors for the immobility time and serotonin levels in the hippocampus and plasma of sub-chronically forced swim stressed rats.

  Pakistan journal of pharmaceutical sciences 20120401

• A simple HPLC method for the simultaneous determination of two selective serotonin reuptake inhibitors and two serotonin-norepinephrine reuptake inhibitors in hair, nail clippings, and cerebrospinal fluid.

  Journal of separation science 20120401

• Effects of amitriptyline, fluoxetine, tranylcypromine and venlafaxine on rat vascular smooth muscle in vitro--the role of the endothelium.

  Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20120401

• The effect of a P123 template in mesopores of mesocellular foam on the controlled-release of venlafaxine.

  International journal of pharmaceutics 20120315

• Occurrence and removal of lidocaine, tramadol, venlafaxine, and their metabolites in German wastewater treatment plants.

  Environmental science and pollution research international 20120301

• Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20120301

• Species comparison of in vivo P-glycoprotein-mediated brain efflux using mdr1a-deficient rats and mice.

  Drug metabolism and disposition: the biological fate of chemicals 20120301

• Cress seed mucilage based buccal mucoadhesive gel of venlafaxine: in vivo, in vitro evaluation.

  Journal of materials science. Materials in medicine 20120301

• A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia.

  Brain, behavior, and immunity 20120301

• Addressing both depression and pain in late life: the methodology of the ADAPT study.

  Pain medicine (Malden, Mass.) 20120301

• Hypoglycaemia: a little known effect of Venlafaxine overdose.

  Clinical toxicology (Philadelphia, Pa.) 20120301

• Does aripiprazole protect from serotonin syndrome?

  Psychiatria Danubina 20120301

• Determination of venlafaxine in post-mortem whole blood by HS-SPME and GC-NPD.

  Forensic science international 20120210

• Enantiomeric profiling of chiral drugs in wastewater and receiving waters.

  Environmental science & technology 20120207

• Stress-induced anhedonia is associated with an increase in Alzheimer's disease-related markers.

  British journal of pharmacology 20120201

• Does early improvement predict endpoint response in patients with generalized anxiety disorder (GAD) treated with pregabalin or venlafaxine XR?

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20120201

• Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STAR*D.

  Journal of clinical psychopharmacology 20120201

• Treatment with duloxetine in adults and the incidence of cardiovascular events.

  Journal of clinical psychopharmacology 20120201

• Treatment of night eating syndrome with topiramate: dawn of a new day.

  Journal of clinical psychopharmacology 20120201

• Negative impact of migraine on quality of life after 4 weeks of treatment in patients with major depressive disorder.

  Psychiatry and clinical neurosciences 20120201

• Out of the black box: treatment of resistant depression in adolescents and the antidepressant controversy.

  Journal of child and adolescent psychopharmacology 20120201

• Adjunctive sleep medications and depression outcome in the treatment of serotonin-selective reuptake inhibitor resistant depression in adolescents study.

  Journal of child and adolescent psychopharmacology 20120201

• Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: an exploratory analysis of a single-blind randomized trial.

  Depression and anxiety 20120201

• Tapentadol increases levels of noradrenaline in the rat spinal cord as measured by in vivo microdialysis.

  Neuroscience letters 20120124

• Venlafaxine and atenolol disrupt epinephrine-stimulated glucose production in rainbow trout hepatocytes.

  Aquatic toxicology (Amsterdam, Netherlands) 20120115

• Influence of CYP2D6 genotype on the disposition of the enantiomers of venlafaxine and its major metabolites in postmortem femoral blood.

  Forensic science international 20120110

• Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120101

• Gene-class analysis of expression patterns induced by psychoactive pharmaceutical exposure in fathead minnow (Pimephales promelas) indicates induction of neuronal systems.

  Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 20120101

• Proinflammatory and 'resiliency' proteins in the CSF of patients with major depression.

  Depression and anxiety 20120101

• Long lasting phantosmia treated with venlafaxine.

  Neurocase 20120101

• Efficacy and tolerability of venlafaxine versus specific serotonin reuptake inhibitors in treatment of major depressive disorder: a meta-analysis of published studies.

  International clinical psychopharmacology 20120101

• Use of venlafaxine in psychiatric disorders and climacteric syndrome: is a therapeutic bridge?

  Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20120101

• Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial.

  The Journal of clinical psychiatry 20120101

• Depression treatment in patients with general medical conditions: results from the CO-MED trial.

  Annals of family medicine 20120101

• Double-blind controlled trial of venlafaxine for treatment of adults with attention deficit/hyperactivity disorder.

  Human psychopharmacology 20120101

• Questions raised by the failure of a trial of short-term psychodynamic therapy versus pharmacotherapy for major depressive disorder.

  The Journal of clinical psychiatry 20120101

• Cost-effectiveness evaluation in Sweden of escitalopram compared with venlafaxine extended-release as first-line treatment in major depressive disorder.

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20120101

• Low-dose venlafaxine-induced severe rhabdomyolysis: a case report.

  General hospital psychiatry 20120101

• Antidepressants and menstruation disorders in women: a cross-sectional study in three centers.

  General hospital psychiatry 20120101

• Psychoactive pharmaceuticals induce fish gene expression profiles associated with human idiopathic autism.

  PloS one 20120101

• Citalopram versus other anti-depressive agents for depression.

  The Cochrane database of systematic reviews 20120101

• Low dosage lithium augmentation in venlafaxine resistant depression: an open-label study.

  Psychiatrike = Psychiatriki 20120101

• Plasma exchange in the management of a case of hypertriglyceridaemic pancreatitis triggered by venlafaxine.

  BMJ case reports 20120101

• Warfarin: pharmacological profile and drug interactions with antidepressants.

  Einstein (Sao Paulo, Brazil) 20120101

• Duloxetine versus other anti-depressive agents for depression.

  The Cochrane database of systematic reviews 20120101

• In vitro effects of serotonin and noradrenaline reuptake inhibitors on human platelet adhesion and coagulation.

  Pharmacological reports : PR 20120101

• Venlafaxine in somatopsychic and autopsychic depersonalization.

  Progress in neuro-psychopharmacology & biological psychiatry 20111201

• Combined medication and cognitive therapy for generalized anxiety disorder.

  Journal of anxiety disorders 20111201

• Time to discontinuation among the three second-generation antidepressants in a naturalistic outpatient setting of depression.

  Psychiatry and clinical neurosciences 20111201

• Effect of acutely and chronically administered venlafaxine on the anticonvulsant action of classical antiepileptic drugs in the mouse maximal electroshock model.

  European journal of pharmacology 20111116

• Reduced right ventrolateral prefrontal cortex activity while inhibiting positive affect is associated with improvement in hedonic capacity after 8 weeks of antidepressant treatment in major depressive disorder.

  Biological psychiatry 20111115

• Selective serotonin re-uptake inhibiting antidepressants and the risk of overanticoagulation during acenocoumarol maintenance treatment.

  British journal of clinical pharmacology 20111101

• Venlafaxine protects against stress-induced oxidative DNA damage in hippocampus during antidepressant testing in mice.

  Pharmacology, biochemistry, and behavior 20111101

• Paroxysmal cervical myoclonus.

  Movement disorders : official journal of the Movement Disorder Society 20111101

• Does the presence of accompanying symptom clusters differentiate the comparative effectiveness of second-line medication strategies for treating depression?

  Depression and anxiety 20111101

• [Cardiogenic shock after venlafaxine poisoning].

  Annales francaises d'anesthesie et de reanimation 20111101

• Summer is the best time for Treatment of Resistant Depression in Adolescents (TORDIA): the importance of school in medication trials.

  Journal of the American Academy of Child and Adolescent Psychiatry 20111101

• Treatment-resistant depressed youth show a higher response rate if treatment ends during summer school break.

  Journal of the American Academy of Child and Adolescent Psychiatry 20111101

• Severe acute cardiomyopathy associated with venlafaxine overdose and possible role of CYP2D6 and CYP2C19 polymorphisms.

  Clinical toxicology (Philadelphia, Pa.) 20111101

• Association analysis between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and treatment response to venlafaxine XR in generalized anxiety disorder.

  Neuroscience letters 20111010

• Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111010

• Nonestrogenic management of hot flashes.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111010

• Novel protective mechanisms of antidepressants against 3-nitropropionic acid induced Huntington's-like symptoms: a comparative study.

  Journal of psychopharmacology (Oxford, England) 20111001

• Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report.

  Journal of affective disorders 20111001

• Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.

  The Journal of clinical psychiatry 20111001

• Serum brain-derived neurotrophic factor and glucocorticoid receptor levels in lymphocytes as markers of antidepressant response in major depressive patients: a pilot study.

  Psychiatry research 20110930

• Evaluation of antidepressant activity of 1-(7-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-4-YL)-cyclohexanol, a β-substituted phenylethylamine in mice.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20110901

• Venlafaxine pharmacobezoar causing intestinal ischemia requiring emergent hemicolectomy.

  Journal of medical toxicology : official journal of the American College of Medical Toxicology 20110901

• Venlafaxine inhibits the development and differentiation of dendritic cells through the regulation of P-glycoprotein.

  International immunopharmacology 20110901

• Metabonomic study on chronic unpredictable mild stress and intervention effects of Xiaoyaosan in rats using gas chromatography coupled with mass spectrometry.

  Journal of ethnopharmacology 20110901

• Clinical outcomes following switch from venlafaxine ER to desvenlafaxine in nonresponders and responders.

  Current medical research and opinion 20110901

• [Effect of venlafaxine on cognitive function and hippocampal brain-derived neurotrophic factor expression in rats with post-stroke depression].

  Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20110901

• The effects of antidepressants and pilocarpine on rat parotid glands: an immunohistochemical study.

  Clinics (Sao Paulo, Brazil) 20110901

• Poly(lactic acid)-coated mesoporous silica nanosphere for controlled release of venlafaxine.

  Journal of colloid and interface science 20110815

• Venlafaxine or a second SSRI: Switching after treatment failure with an SSRI among depressed inpatients: a retrospective analysis.

  Progress in neuro-psychopharmacology & biological psychiatry 20110815

• Effects of venlafaxine and escitalopram treatments on NMDA receptors in the rat depression model.

  The Journal of membrane biology 20110801

• Suicide attempts and nonsuicidal self-injury in the treatment of resistant depression in adolescents: findings from the TORDIA study.

  Journal of the American Academy of Child and Adolescent Psychiatry 20110801

• A simple HPLC method for the simultaneous determination of venlafaxine and its major metabolite O-desmethylvenlafaxine in human serum.

  Bioanalysis 20110801

• Serum lipoproteins improve after successful pharmacologic antidepressant treatment: a randomized open-label prospective trial.

  The Journal of clinical psychiatry 20110701

• The effect of decontamination procedures on the pharmacodynamics of venlafaxine in overdose.

  British journal of clinical pharmacology 20110701

• Venlafaxine-induced delirium.

  The Australian and New Zealand journal of psychiatry 20110701

• Selective uptake and biological consequences of environmentally relevant antidepressant pharmaceutical exposures on male fathead minnows.

  Aquatic toxicology (Amsterdam, Netherlands) 20110701

• Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study.

  The American journal of psychiatry 20110701

• Treatment adherence and persistence with duloxetine, venlafaxine XR, and escitalopram among patients with major depressive disorder and chronic pain-related diseases.

  Current medical research and opinion 20110701

• Hyponatremia associated with selective serotonin reuptake inhibitors, mirtazapine, and venlafaxine in Korean patients with major depressive disorder.

  International journal of clinical pharmacology and therapeutics 20110701

• Rostral anterior cingulate cortex activity and early symptom improvement during treatment for major depressive disorder.

  Psychiatry research 20110630

• Drugs and pheochromocytoma--don't be fooled by every elevated metanephrine.

  The New England journal of medicine 20110609

• Comparative study of the stability of venlafaxine hydrochloride sustained-release pellets prepared by double-polymer coatings and hot-melt subcoating combined with Eudragit(®) NE30D outercoating.

  Pharmaceutical development and technology 20110601

• Health-related quality of life in a clinical trial of ECT followed by continuation pharmacotherapy: effects immediately after ECT and at 24 weeks.

  The journal of ECT 20110601

• Remission of major depressive disorder without adverse events: a comparison of escitalopram versus serotonin norepinephrine reuptake inhibitors.

  Current medical research and opinion 20110601

• Hippocampal CA3 calcineurin activity participates in depressive-like behavior in rats.

  Journal of neurochemistry 20110601

• Antidepressant use during pregnancy. FPIN’s clinical inquiries.

  American family physician 20110515

• Cognitive deterioration after venlafaxine overdose.

  The Journal of emergency medicine 20110501

• Fatal venlafaxine poisonings are associated with a high prevalence of drug interactions.

  International journal of legal medicine 20110501

• Modulation of neuroplastic molecules in selected brain regions after chronic administration of the novel antidepressant agomelatine.

  Psychopharmacology 20110501

• Effects on enantiomeric drug disposition and open-field behavior after chronic treatment with venlafaxine in the P-glycoprotein knockout mice model.

  Psychopharmacology 20110501

• Neural correlates of treatment outcome in major depression.

  The international journal of neuropsychopharmacology 20110501

• Induction of drug efflux protein expression by venlafaxine but not desvenlafaxine.

  Biopharmaceutics & drug disposition 20110501

• Pharmacokinetically and clinician-determined adherence to an antidepressant regimen and clinical outcome in the TORDIA trial.

  Journal of the American Academy of Child and Adolescent Psychiatry 20110501

• Severe mania complicating treatment of narcolepsy with cataplexy.

  Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20110415

• A rapid, Web-based method for obtaining patient views on effects and side-effects of antidepressants.

  Journal of affective disorders 20110401

• A systematic review of duloxetine and venlafaxine in major depression, including unpublished data.

  Acta psychiatrica Scandinavica 20110401

• Different effects of mirtazapine and venlafaxine on brain activation: an open randomized controlled fMRI study.

  The Journal of clinical psychiatry 20110401

• CYP 2D6 PM status and antidepressant response to nortriptyline and venlafaxine: is it more than just drug metabolism?

  Journal of clinical psychopharmacology 20110401

• What can we learn from Chinese randomized controlled trials? A systematic review and meta-analysis of Chinese venlafaxine studies.

  Journal of clinical psychopharmacology 20110401

• Paliperidone augmentation for treatment-resistant depression: a case report.

  Journal of clinical psychopharmacology 20110401

• Acute eosinophilic pneumonia after venlafaxine overdose.

  Journal of clinical psychopharmacology 20110401

• The psychoactive effects of antidepressants and their association with suicidality.

  Current drug safety 20110401

• Balance control improves following replacement of paroxetine with venlafaxine and levodopa in a case of microvascular dementia.

  The American journal of geriatric pharmacotherapy 20110401

• Electroconvulsive therapy in older adults.

  Medicine and health, Rhode Island 20110401

• The antidepressant action of imipramine and venlafaxine involves suppression of nitric oxide synthesis.

  Behavioural brain research 20110317

• Comparing venlafaxine extended release and fluoxetine for preventing the recurrence of major depression: results from the PREVENT study.

  Journal of psychiatric research 20110301

• Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sample.

  The Journal of clinical psychiatry 20110301

• Venlafaxine modulates depression-induced behaviour and the expression of Bax mRNA and Bcl-xl mRNA in both hippocampus and myocardium.

  Human psychopharmacology 20110301

• Development and validation of a HPLC-MS/MS method for the determination of venlafaxine enantiomers and application to a pharmacokinetic study in healthy Chinese volunteers.

  Biomedical chromatography : BMC 20110301

• Incremental cost-effectiveness of combined therapy vs medication only for youth with selective serotonin reuptake inhibitor-resistant depression: treatment of SSRI-resistant depression in adolescents trial findings.

  Archives of general psychiatry 20110301

• Dermatitis artefacta--a long way from the first clinical symptoms to diagnosis.

  Psychiatria Danubina 20110301

• Venlafaxine withdrawal syndrome.

  Psychiatria Danubina 20110301

• Clinical and genetic correlates of suicidal ideation during antidepressant treatment in a depressed outpatient sample.

  Pharmacogenomics 20110301

• TPH1 is associated with major depressive disorder but not with SSRI/SNRI response in Taiwanese patients.

  Psychopharmacology 20110201

• In vivo, in vitro evaluation of linseed mucilage based buccal mucoadhesive microspheres of venlafaxine.

  Drug delivery 20110201

• Effect of cytochrome P450 enzyme polymorphisms on pharmacokinetics of venlafaxine.

  Therapeutic drug monitoring 20110201

• A case of venlafaxine-induced bruxism alleviated by duloxetine substitution.

  Progress in neuro-psychopharmacology & biological psychiatry 20110115

• Noradrenergic function in generalized anxiety disorder: impact of treatment with venlafaxine on the physiological and psychological responses to clonidine challenge.

  Journal of psychopharmacology (Oxford, England) 20110101

• Lipid therapy for serotonin syndrome after intoxication with venlafaxine, lamotrigine and diazepam.

  Minerva anestesiologica 20110101

• Quantification of antidepressants and antipsychotics in human serum by precipitation and ultra high pressure liquid chromatography-tandem mass spectrometry.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110101

• Bioequivalence of venlafaxine modified-release capsule revisited with an innovative approach using experimental and predictive models.

  Bioanalysis 20110101

• International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol.

  Trials 20110101

• Functional gastrointestinal disorders: Venlafaxine is a potential therapy for functional chest pain.

  Nature reviews. Gastroenterology & hepatology 20110101

• Treatment patterns associated with Duloxetine and Venlafaxine use for Major Depressive Disorder.

  BMC psychiatry 20110101

• Pharmacokinetics of venlafaxine extended release 75  mg and desvenlafaxine 50  mg in healthy CYP2D6 extensive and poor metabolizers: a randomized, open-label, two-period, parallel-group, crossover study.

  Clinical drug investigation 20110101

• [Patch testing increases the likelihood of recognizing lamotrigine as a cause of drug-induced rash].

  Actas dermo-sifiliograficas 20110101

• [Treatment-resistant depressions in borderline psychiatry].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20110101

• Treatment of neuropathic pain in patients with chronic kidney disease.

  CANNT journal = Journal ACITN 20110101

• Psychological factors affecting response to antidepressant drugs in fibromyalgia.

  Psychosomatics 20110101

• Two cases of serotonin syndrome with venlafaxine and calcineurin inhibitors.

  Psychosomatics 20110101

• Repetitive transcranial magnetic stimulation or venlafaxine-induced mania?

  The Journal of neuropsychiatry and clinical neurosciences 20110101

• Venlafaxine and excessive yawning: is there any link?

  The Journal of neuropsychiatry and clinical neurosciences 20110101

• Venlafaxine-induced acute eosinophilic pneumonia.

  General hospital psychiatry 20110101

• Early syphilitic meningoencephalitis masquerading as postclimacteric endogenous depression--a unique dermatologic presentation.

  Akusherstvo i ginekologiia 20110101

• [Serotonin syndrome in the course of drug-poisoning--case presentation].

  Przeglad lekarski 20110101

• Mirtazapine versus other antidepressive agents for depression.

  The Cochrane database of systematic reviews 20110101

• Inhibition of G protein-activated inwardly rectifying K+ channels by different classes of antidepressants.

  PloS one 20110101

• [Syndrome of inappropriate antidiuretic hormone secretion in the course of treatment with venlafaxine--case report].

  Psychiatria polska 20110101

• [The state of nociceptive and antinociceptive brain systems in patients with the pain form of diabetic polyneuropathy].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20110101

• Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101210

• Brain functional changes (QEEG cordance) and worsening suicidal ideation and mood symptoms during antidepressant treatment.

  Acta psychiatrica Scandinavica 20101201

• Physician speciality and pain reduction in patients with depressive symptoms under treatment with venlafaxine.

  European psychiatry : the journal of the Association of European Psychiatrists 20101201

• Antidepressants for neuropathic pain: a Cochrane review.

  Journal of neurology, neurosurgery, and psychiatry 20101201

• Electroconvulsive therapy for lycanthropy and Cotard syndrome: a case report.

  The journal of ECT 20101201

• Comparison of escitalopram vs. citalopram and venlafaxine in the treatment of major depression in Spain: clinical and economic consequences.

  Current medical research and opinion 20101201

• Impact of antidepressant treatment history on clinical outcomes in placebo and medication treatment of major depression.

  Journal of clinical psychopharmacology 20101201

• Late-onset galactorrhea and menometrorrhagia with venlafaxine use in a migraine patient.

  Journal of clinical psychopharmacology 20101201

• Venlafaxine associated urinary symptoms.

  The Australian and New Zealand journal of psychiatry 20101201

• Time to relapse after 6 and 12 months' treatment of generalized anxiety disorder with venlafaxine extended release.

  Archives of general psychiatry 20101201

• Venlafaxine plus mirtazapine as first-line treatment for melancholia: preliminary results.

  Journal of psychopharmacology (Oxford, England) 20101201

• Identification of human Ether-à-go-go related gene modulators by three screening platforms in an academic drug-discovery setting.

  Assay and drug development technologies 20101201

• Evaluation of a QT nomogram for risk assessment after antidepressant overdose.

  British journal of clinical pharmacology 20101201

• Stereoselective determination of venlafaxine and its three demethylated metabolites in human plasma and whole blood by liquid chromatography with electrospray tandem mass spectrometric detection and solid phase extraction.

  Journal of pharmaceutical and biomedical analysis 20101102

• Cytochrome P450 2D6 phenotype predicts antidepressant efficacy of venlafaxine: a secondary analysis of 4 studies in major depressive disorder.

  The Journal of clinical psychiatry 20101101

• Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release.

  Journal of affective disorders 20101101

• Brain derived neurotrophic factor gene polymorphism (Val66Met) and short-term antidepressant response in major depressive disorder.

  Journal of affective disorders 20101101

• Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial.

  Human psychopharmacology 20101101

• Was Cipriani right? Audits to compare discharge rates and suicidality between antidepressant monotherapies used in a British community mental health team.

  Psychiatria Danubina 20101101

• Clinical and therapeutic aspects of childhood narcolepsy-cataplexy: a retrospective study of 51 children.

  Sleep 20101101

• Relative bioavailability of two formulations of venlafaxine extended-release 75-mg capsules in healthy brazilian male volunteers: A single-dose, randomized-sequence, open-label, two-period crossover study in the fasting and fed states.

  Clinical therapeutics 20101101

• Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment.

  Journal of psychiatric research 20101001

• Venlafaxine-associated serotonin syndrome causing severe rhabdomyolysis and acute renal failure in a patient with idiopathic Parkinson disease.

  Journal of clinical psychopharmacology 20101001

• Improving fragile X-associated tremor/ataxia syndrome symptoms with memantine and venlafaxine.

  Journal of clinical psychopharmacology 20101001

• Reduced signal transduction by 5-HT4 receptors after long-term venlafaxine treatment in rats.

  British journal of pharmacology 20101001

• Pediatric emergency medicine: legal briefs.

  Pediatric emergency care 20101001

• Association between antidepressant use during pregnancy and infants born small for gestational age.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20101001

• Protective effect of desipramine, venlafaxine and trazodone against experimental animal model of transient global ischemia: possible involvement of NO-cGMP pathway.

  Brain research 20100924

• Antidepressant-like effect of venlafaxine is abolished in μ-opioid receptor-knockout mice.

  Journal of pharmacological sciences 20100916

• Differential outcomes from metabolic ratios in the identification of CYP2D6 phenotypes--focus on venlafaxine and O-desmethylvenlafaxine.

  European journal of clinical pharmacology 20100901

• Blood-brain barrier penetration of the enantiomers of venlafaxine and its metabolites in mice lacking P-glycoprotein.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20100901

• Optimization and in vivo pharmacokinetic study of a novel controlled release venlafaxine hydrochloride three-layer tablet.

  AAPS PharmSciTech 20100901

• Trends in the consumption of antidepressants in Castilla y León (Spain). Association between suicide rates and antidepressant drug consumption.

  Pharmacoepidemiology and drug safety 20100901

• Neonatal seizures on EEG after in utero exposure to venlafaxine.

  British journal of clinical pharmacology 20100901

• Efficacy and tolerability of venlafaxine extended release in patients with major depressive disorder.

  Psychiatria Danubina 20100901

• The bipolar spectrum: do we need a single algorithm for affective disorders?

  Psychiatria Danubina 20100901

• Gambling on acamprosate: a case report.

  The Journal of clinical psychiatry 20100901

• Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.

  Journal of psychopharmacology (Oxford, England) 20100801

• Chronic stress and antidepressant treatment have opposite effects on P-glycoprotein at the blood-brain barrier: an experimental PET study in rats.

  Journal of psychopharmacology (Oxford, England) 20100801

• Broken heart syndrome: Tako Tsubo cardiomyopathy associated with an overdose of the serotonin-norepinephrine reuptake inhibitor Venlafaxine.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20100801

• Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.

  Journal of clinical psychopharmacology 20100801

• Treatment of psychotic depression in the elderly compared with nonpsychotic depression.

  Journal of clinical psychopharmacology 20100801

• Clinically relevant pharmacokinetic interaction between venlafaxine and bupropion: a case series.

  Journal of clinical psychopharmacology 20100801

• Chronic effects of venlafaxine on synaptophysin and neuronal cell adhesion molecule in the hippocampus of cerebral ischemic mice.

  Biochemistry and cell biology = Biochimie et biologie cellulaire 20100801

• Serotonin transporter gene polymorphism associated with short-term treatment response to venlafaxine.

  Neuropsychobiology 20100801

• Use of antidepressants during pregnancy and the risk of spontaneous abortion.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20100713

• [Delayed seizures after topiramate, venlafaxine and quetiapine overdose].

  Medicina clinica 20100703

• Enantiomeric analysis of drugs of abuse in wastewater by chiral liquid chromatography coupled with tandem mass spectrometry.

  Journal of chromatography. A 20100702

• Sensitive spectrofluorimetric method of analysis for venlafaxine in spiked rat plasma and formulations.

  Journal of fluorescence 20100701

• Does night-time cortisol excretion normalize in the long-term course of depression?

  Pharmacopsychiatry 20100701

• Efficacy of venlafaxine for symptomatic relief in young adult patients with functional chest pain: a randomized, double-blind, placebo-controlled, crossover trial.

  The American journal of gastroenterology 20100701

• Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis.

  International clinical psychopharmacology 20100701

• Treatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomes.

  The American journal of psychiatry 20100701

• The multidisciplinary management of menopausal symptoms after breast cancer: a unique model of care.

  Menopause (New York, N.Y.) 20100701

• Effects of long-term treatment with fluoxetine and venlafaxine on rat isolated vas deferens.

  Autonomic & autacoid pharmacology 20100701

• Editorial: venlafaxine for functional chest pain: hope or hype?

  The American journal of gastroenterology 20100701

• [A painful weaning].

  Revue medicale suisse 20100623

• A comparative study of non-fatal self-poisoning with antidepressants relative to prescribing in three centres in England.

  Journal of affective disorders 20100601

• Long-term response to successful acute pharmacological treatment of psychotic depression.

  Journal of affective disorders 20100601

• Venlafaxine and mirtazapine treatment lowers serum concentrations of dehydroepiandrosterone-sulfate in depressed patients remitting during the course of treatment.

  Journal of psychiatric research 20100601

• Intralipid reverses coma associated with zopiclone and venlafaxine overdose.

  European journal of anaesthesiology 20100601

• Selective serotonin reuptake inhibitors and the risk of cataracts: a nested case-control study.

  Ophthalmology 20100601

• A comparison of venlafaxine and SSRIs in deliberate self-poisoning.

  Journal of medical toxicology : official journal of the American College of Medical Toxicology 20100601

• Evaluation of efficacy of the perioperative administration of Venlafaxine or gabapentin on acute and chronic postmastectomy pain.

  The Clinical journal of pain 20100601

• An audit to compare discharge rates between antidepressant monotherapies prescribed for pure unipolar depression versus depression in the presence of other indications.

  Psychiatria Danubina 20100601

• An audit to compare discharge rates and suicidality between antidepressant monotherapies prescribed for unipolar depression.

  Psychiatria Danubina 20100601

• Suicide risk and choice of antidepressant.

  Psychiatria Danubina 20100601

• Venlafaxine - quetiapine combination in the treatment of complicated clinical picture of enduring personality changes following PTSD in comorbidity with psychotic depression.

  Psychiatria Danubina 20100601

• Effect of venlafaxine and nicotine on the level of neurotransmitters and their metabolites in rat brains.

  Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20100601

• Evaluation of Krebs cycle enzymes in the brain of rats after chronic administration of antidepressants.

  Brain research bulletin 20100531

• Deaths involving serotonergic drugs.

  Forensic science international 20100520

• Correlation between patient and clinician assessments of depression severity in the PREVENT study.

  Psychiatry research 20100515

• Antidepressant treatment with mirtazapine, but not venlafaxine, lowers cortisol concentrations in saliva: a randomised open trial.

  Psychiatry research 20100515

• [Idiopathic intracranial hypertension and pregnancy. A report of two cases].

  Journal de gynecologie, obstetrique et biologie de la reproduction 20100501

• [Risperidone intoxication in a patient with a genetic predisposition as 'poor [non]metabolizer'].

  Psychiatrische Praxis 20100501

• Healthcare expenditure in severely depressed patients treated with escitalopram, generic SSRIs or venlafaxine in the UK.

  Current medical research and opinion 20100501

• Outliers on the dose-response curve: how to minimize this problem using therapeutic drug monitoring, an underutilized tool in psychiatry.

  Journal of psychiatric practice 20100501

• Effect of anti-depressants on neuro-behavioural consequences following impact accelerated traumatic brain injury in rats.

  Indian journal of experimental biology 20100501

• Conventional and complementary therapies: a tale of two research standards?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100420

• The pharmacokinetics of standard antidepressants with aripiprazole as adjunctive therapy: studies in healthy subjects and in patients with major depressive disorder.

  Journal of psychopharmacology (Oxford, England) 20100401

• Venlafaxine-associated nocturnal bruxism in a depressive patient successfully treated with buspirone.

  Journal of psychopharmacology (Oxford, England) 20100401

• [Depressive symptoms in a case of 'posterior cortical atrophy'].

  Fortschritte der Neurologie-Psychiatrie 20100401

• The venlafaxine 'heart revenge:' a short report.

  Clinical cardiology 20100401

• Lack of preparation, physical health after childbirth, and early postpartum depressive symptoms.

  Journal of women's health (2002) 20100401

• Psychiatric concerns in pediatric epilepsy.

  Child and adolescent psychiatric clinics of North America 20100401

• Changes in antidepressant metabolism in pregnancy evidenced by metabolic ratios in hair: a novel approach.

  Forensic science international 20100320

• Psychogenic movement disorder after a venlafaxine-induced dystonia.

  Movement disorders : official journal of the Movement Disorder Society 20100315

• Treatment of unipolar psychotic depression: a randomized, double-blind study comparing imipramine, venlafaxine, and venlafaxine plus quetiapine.

  Acta psychiatrica Scandinavica 20100301

• Venlafaxine monotherapy in bipolar type II depressed patients unresponsive to prior lithium monotherapy.

  Acta psychiatrica Scandinavica 20100301

• Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.

  The American journal of psychiatry 20100301

• Simultaneous quantification of venlafaxine and O-desmethylvenlafaxine in human plasma by ultra performance liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20100301

• Combining antidepressant medications: a good idea?

  The American journal of psychiatry 20100301

• Management of depression in the presence of pain symptoms.

  Psychiatria Danubina 20100301

• Involvement of potassium channels in the antidepressant-like effect of venlafaxine in mice.

  Life sciences 20100227

• Venlafaxine and cardiovascular toxicity.

  BMJ (Clinical research ed.) 20100205

• Normalization of GRK2 protein and mRNA measures in patients with depression predict response to antidepressants.

  The international journal of neuropsychopharmacology 20100201

• Cost-effectiveness of pregabalin versus venlafaxine in the treatment of generalized anxiety disorder: findings from a Spanish perspective.

  The European journal of health economics : HEPAC : health economics in prevention and care 20100201

• Effects of venlafaxine and fluoxetine on lymphocyte subsets in patients with major depressive disorder: a flow cytometric analysis.

  Progress in neuro-psychopharmacology & biological psychiatry 20100201

• Neonatal hair analysis by liquid chromatography-high-resolution mass spectrometry to reveal gestational exposure to venlafaxine.

  Therapeutic drug monitoring 20100201

• Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial.

  The Lancet. Oncology 20100201

• Association of FKBP5 polymorphisms with suicidal events in the Treatment of Resistant Depression in Adolescents (TORDIA) study.

  The American journal of psychiatry 20100201

• Acupuncture versus venlafaxine for the management of vasomotor symptoms in patients with hormone receptor-positive breast cancer: a randomized controlled trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100201

• Use of venlafaxine in the treatment of a canine narcolepsy-cataplexy case.

  The Journal of small animal practice 20100201

• [Cholinesterase inhibitors and depression in the elderly].

  L'Encephale 20100201

• Cardiogenic shock associated with reversible dilated cardiomyopathy during therapy with regular doses of venlafaxine.

  The American journal of emergency medicine 20100201

• When is a 'generic' medication not really a generic?

  Journal of psychosocial nursing and mental health services 20100201

• Teaching case: menopausal migraine.

  Headache 20100201

• [Discontinuation of antidepressant serotonergic antidepressant].

  Ugeskrift for laeger 20100125

• Venlafaxine involves nitric oxide modulatory mechanism in experimental model of chronic behavior despair in mice.

  Brain research 20100122

• Development of a stir bar sorptive extraction based HPLC-FLD method for the quantification of serotonin reuptake inhibitors in plasma, urine and brain tissue samples.

  Journal of pharmaceutical and biomedical analysis 20100105

• Regional origin and decrease of pain in patients with depressive symptoms under treatment with venlafaxine.

  Social psychiatry and psychiatric epidemiology 20100101

• Economic evaluation of duloxetine versus serotonin selective reuptake inhibitors and venlafaxine XR in treating major depressive disorder in Scotland.

  Journal of affective disorders 20100101

• Antidepressant response trajectories and quantitative electroencephalography (QEEG) biomarkers in major depressive disorder.

  Journal of psychiatric research 20100101

• Effects of aripiprazole adjunctive to standard antidepressant treatment on the core symptoms of depression: a post-hoc, pooled analysis of two large, placebo-controlled studies.

  Journal of affective disorders 20100101

• To sweat or not to sweat? A hypothesis on the effects of venlafaxine and SSRIs.

  Medical hypotheses 20100101

• Chiral HPLC analysis of venlafaxine metabolites in rat liver microsomal preparations after LPME extraction and application to an in vitro biotransformation study.

  Analytical and bioanalytical chemistry 20100101

• Combating depression in Huntington's disease: effective antidepressive treatment with venlafaxine XR.

  International clinical psychopharmacology 20100101

• Venlafaxine, but not mirtazapine lowers retinol-binding protein 4 serum concentrations in nondiabetic depressed patients.

  Psychotherapy and psychosomatics 20100101

• Understanding outliers on the usual dose-response curve: venlafaxine as a way to phenotype patients in terms of their CYP 2D6 status and why it matters.

  Journal of psychiatric practice 20100101

• Dosing by side effect threshold: two cases of panic disorder responsive to low-dose venlafaxine.

  The Journal of clinical psychiatry 20100101

• Use of venlafaxine compared with other antidepressants and the risk of sudden cardiac death or near death: a nested case-control study.

  BMJ (Clinical research ed.) 20100101

• Correction of venlafaxine- and duloxetine-induced transaminase elevations with desvenlafaxine in a patient with Gilbert's syndrome.

  CNS spectrums 20100101

• Repeated angioedema following administration of venlafaxine and mirtazapine.

  General hospital psychiatry 20100101

• Manic episode following a combined treatment of repetitive transcranial magnetic stimulation and venlafaxine.

  The Journal of neuropsychiatry and clinical neurosciences 20100101

• [Headaches of tension and psychogenic headaches: assessment of the treatment with venlafaxine].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20100101

• Multifactorial QT interval prolongation.

  Cardiology journal 20100101

• Effect of venlafaxine on bone loss associated with ligature-induced periodontitis in Wistar rats.

  Journal of negative results in biomedicine 20100101

• Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial.

  Menopause (New York, N.Y.) 20100101

• Perimenopausal postpartum depression after conception by assisted reproductive technology.

  Psychosomatics 20100101

• Pharmacologic management of trigeminal nerve injury pain after dental implant surgery.

  The International journal of prosthodontics 20100101

• The effect of newer serotonin-noradrenalin antidepressants on cytokine production: a review of the current literature.

  International journal of immunopathology and pharmacology 20100101

• Cost effectiveness of escitalopram versus SNRIs in second-step treatment of major depressive disorder in Sweden.

  Journal of medical economics 20100101

• Multiple pulmonary thromboembolism and severe depression.

  General hospital psychiatry 20100101

• Duloxetine versus venlafaxine in the treatment of unipolar and bipolar depression.

  La Clinica terapeutica 20100101

• Efficiency of venlafaxine in patients with psychogenic nonepileptic seizures and anxiety and/or depressive disorders.

  The Journal of neuropsychiatry and clinical neurosciences 20100101

• Patient outcomes with education, drug therapy, and support: a study of venlafaxine ER-treated outpatients with major depressive disorder.

  Psychopharmacology bulletin 20100101

• [Clinical features of headache of tension type and principles of treatment].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20100101

• [New approaches to the treatment of chronic daily headache].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20100101

• Comparison of the effectiveness of venlafaxine in peri- and postmenopausal patients with major depressive disorder.

  Actas espanolas de psiquiatria 20100101

• Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.

  Neuro endocrinology letters 20100101

• [Acute lethal poisoning with venlafaxine].

  Przeglad lekarski 20100101

• IFN-gamma reduction by tricyclic antidepressants.

  International journal of psychiatry in medicine 20100101

• Nitric oxide mechanism in protective effect of imipramine and venlafaxine against acute immobilization stress-induced behavioral and biochemical alteration in mice.

  Neuroscience letters 20091225

• Brain creatine kinase activity is increased by chronic administration of paroxetine.

  Brain research bulletin 20091216

• Rapid high-performance liquid chromatography-tandem mass spectrometry method for simultaneous measurement of venlafaxine and O-desmethylvenlafaxine in human plasma and its application in comparative bioavailability study.

  Biomedical chromatography : BMC 20091201

• Substance use and the treatment of resistant depression in adolescents.

  Journal of the American Academy of Child and Adolescent Psychiatry 20091201

• [Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study].

  L'Encephale 20091201

• Agomelatine: new drug. Adverse effects and no proven efficacy.

  Prescrire international 20091201

• Efficacy of tramadol in combination with doxepin or venlafaxine in inhibition of nociceptive process in the rat model of neuropathic pain: an isobolographic analysis.

  Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20091201

• Interactions between tamoxifen and antidepressants via cytochrome P450 2D6.

  The Journal of clinical psychiatry 20091201

• Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study.

  Journal of affective disorders 20091101

• Early response as predictor of final remission in elderly depressed patients.

  International journal of geriatric psychiatry 20091101

• Frontal EEG predictors of treatment outcome in major depressive disorder.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20091101

• Depressive effect of an antidepressant: therapeutic failure of venlafaxine in a case lacking CYP2D6 activity.

  Annals of clinical biochemistry 20091101

• What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression.

  Psychiatric services (Washington, D.C.) 20091101

• Pharmacogenetics studies in STAR*D: strengths, limitations, and results.

  Psychiatric services (Washington, D.C.) 20091101

• [Therapeutic effects of venlafaxine extended release for patients with depressive and anxiety disorders in the German outpatient setting - results of 2 observational studies including 8500 patients].

  Fortschritte der Neurologie-Psychiatrie 20091101

• Tricyclic antidepressant toxicity treated with massive sodium bicarbonate.

  The American journal of emergency medicine 20091101

• Bioequivalence of single and multiple doses of venlafaxine extended-release tablets and capsules in the fasted and fed states: four open-label, randomized crossover trials in healthy volunteers.

  Clinical therapeutics 20091101

• The course of adverse effects of nortriptyline and venlafaxine in elderly patients with major depression.

  Journal of the American Geriatrics Society 20091101

• Symptoms of delusion: the effects of discontinuation of low-dose venlafaxine.

  Acta psychiatrica Scandinavica 20091001

• The effect of decontamination procedures on the pharmacokinetics of venlafaxine in overdose.

  Clinical pharmacology and therapeutics 20091001

• Simultaneous determination of venlafaxine and its main active metabolite O-desmethyl venlafaxine in rat plasma by LC-MS/MS.

  Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20091001

• Development and validation of a stability-indicating LC method for the determination of venlafaxine in extended-release capsules and dissolution kinetic studies.

  Journal of chromatographic science 20091001

• Fulminant hepatic failure induced by venlafaxine and trazodone therapy: a case report.

  Transplantation proceedings 20091001

• Mirtazapine versus venlafaxine for the treatment of somatic symptoms associated with major depressive disorder: a randomized, open-labeled trial.

  Psychiatry research 20090930

• Venlafaxine treatment stimulates expression of brain-derived neurotrophic factor protein in frontal cortex and inhibits long-term potentiation in hippocampus.

  Neuroscience 20090915

• Venlafaxine-associated tinnitus.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20090915

• High-dose venlafaxine in delusional and severely depressed patients.

  Journal of psychopharmacology (Oxford, England) 20090901

• Differential effects of venlafaxine in the treatment of major depressive disorder according to baseline severity.

  European archives of psychiatry and clinical neuroscience 20090901

• Regarding 'Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs'.

  Biological psychiatry 20090901

• Venlafaxine in human breast milk and nursing infant plasma: determination of exposure.

  The Journal of clinical psychiatry 20090901

• Changes in medial prefrontal cortex neural responses parallel successful antidepressant combination of venlafaxine and light therapy.

  Archives italiennes de biologie 20090901

• A comparison of several approaches for choosing between working correlation structures in generalized estimating equation analysis of longitudinal binary data.

  Statistics in medicine 20090815

• Efficacy of venlafaxine compared with tricyclic antidepressants in depressive disorder: a meta-analysis.

  Journal of psychopharmacology (Oxford, England) 20090801

• Rapid and reliable genotyping procedure for detection of alleles with mutations, deletion, or/and duplication of the CYP2D6 gene.

  Clinical biochemistry 20090801

• Is psychopharmacologic treatment associated with neuropsychological deficits in bipolar youth?

  The Journal of clinical psychiatry 20090801

• Venlafaxine metabolism as a marker of cytochrome P450 enzyme 2D6 metabolizer status.

  Journal of clinical psychopharmacology 20090801

• TORDIA: unique opportunity to explore half-life theory.

  The American journal of psychiatry 20090801

• Rapid HPLC method for the simultaneous monitoring of duloxetine, venlaflaxine, fluoxetine and paroxetine in biofluids.

  Bioanalysis 20090801

• Comparative study on the gastroprotective potential of some antidepressants in indomethacin-induced ulcer in rats.

  Chemico-biological interactions 20090715

• Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.

  Journal of psychopharmacology (Oxford, England) 20090701

• Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression.

  Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 20090701

• Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes: short-term efficacy and adverse effects.

  Archives of general psychiatry 20090701

• Comparison of pharmacokinetic profiles of brand-name and generic formulations of citalopram and venlafaxine: a crossover study.

  The Journal of clinical psychiatry 20090701

• [Venlafaxine-containing prolonged release: critical exchange?].

  Medizinische Monatsschrift fur Pharmazeuten 20090701

• Venlafaxine-induced excessive yawning: a thermoregulatory connection.

  Progress in neuro-psychopharmacology & biological psychiatry 20090615

• Dose-related hyperprolactinemia induced by venlafaxine.

  Progress in neuro-psychopharmacology & biological psychiatry 20090615

• Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study.

  Breast cancer research and treatment 20090601

• Direct high-performance liquid chromatographic separation of the enantiomers of venlafaxine and 11 analogs using amylose-derived chiral stationary phases.

  Chirality 20090601

• The SNRI venlafaxine improves emotional unawareness in patients with post-stroke depression.

  Human psychopharmacology 20090601

• Fabrication of triple-layer matrix tablets of venlafaxine hydrochloride using xanthan gum.

  AAPS PharmSciTech 20090601

• Maternal use of venlafaxine near term: correlation between neonatal effects and plasma concentrations.

  Therapeutic drug monitoring 20090601

• [Horner's syndrome unmasked by venlafaxine].

  Revista de neurologia 20090601

• Selective serotonin reuptake inhibitors are associated with a modest increase in the risk of upper gastrointestinal bleeding.

  The American journal of gastroenterology 20090601

• Escitalopram versus SNRI antidepressants in the acute treatment of major depressive disorder: integrative analysis of four double-blind, randomized clinical trials.

  CNS spectrums 20090601

• [Psycho- and pharmacotherapy of depressions. So you combine correctly].

  MMW Fortschritte der Medizin 20090507

• Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode?

  Journal of affective disorders 20090501

• The antidepressant venlafaxine ameliorates murine experimental autoimmune encephalomyelitis by suppression of pro-inflammatory cytokines.

  The international journal of neuropsychopharmacology 20090501

• Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20090501

• Change in formulation and its potential clinical and pharmacoeconomic value: example of extended release venlafaxine.

  Current medical research and opinion 20090501

• Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus.

  The American journal of psychiatry 20090501

• Antidepressant switching among adherent patients treated for depression.

  Psychiatric services (Washington, D.C.) 20090501

• Nontricyclic antidepressants for neuropathic pain #187.

  Journal of palliative medicine 20090501

• [Venlafaxine-induced cholestatic hepatitis].

  Gastroenterologia y hepatologia 20090501

• Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder.

  Journal of psychiatry & neuroscience : JPN 20090501

• Borderline personality disorder: inpatient psychiatric nursing management.

  Journal of psychosocial nursing and mental health services 20090501

• Electrocardiogram changes and arrhythmias in venlafaxine overdose.

  British journal of clinical pharmacology 20090501

• Development of an in-capillary approach to nanoscale automated in vitro cytochromes p450 assays.

  Journal of medicinal chemistry 20090423

• Outcome of late-life depression after 3 years of sequential treatment.

  Acta psychiatrica Scandinavica 20090401

• Brain functional changes during placebo lead-in and changes in specific symptoms during pharmacotherapy for major depression.

  Acta psychiatrica Scandinavica 20090401

• The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.

  European archives of psychiatry and clinical neuroscience 20090401

• Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study.

  The American journal of psychiatry 20090401

• Teenaged, depressed, and treatment resistant: what predicts self-harm?

  The American journal of psychiatry 20090401

• A double-blind, placebo-controlled, parallel-group, flexible-dose study of venlafaxine extended release capsules in adult outpatients with panic disorder.

  The Journal of clinical psychiatry 20090401

• Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study.

  The Journal of clinical psychiatry 20090401

• Treatment with venlafaxine in six cases of children with narcolepsy and with cataplexy and hypnagogic hallucinations.

  Journal of child and adolescent psychopharmacology 20090401

• [Severe forms of depression: the efficacy of escitalopram].

  L'Encephale 20090401

• Venlafaxine-induced complex visual hallucinations in a 17-year-old boy.

  The Journal of clinical psychiatry 20090401

• An integrated analysis of the safety and tolerability of desvenlafaxine compared with placebo in the treatment of major depressive disorder.

  CNS spectrums 20090401

• Big interest in heavy drugs.

  Nature 20090319

• Invivo antioxidant status: a putative target of antidepressant action.

  Progress in neuro-psychopharmacology & biological psychiatry 20090317

• Effects of fluoxetine and venlafaxine on serum brain derived neurotrophic factor levels in depressed patients.

  Progress in neuro-psychopharmacology & biological psychiatry 20090317

• The influences of depression and venlafaxine use at therapeutic doses on atrial conduction.

  Journal of psychopharmacology (Oxford, England) 20090301

• The efficacy of venlafaxine in the treatment of women with stress urinary incontinence.

  Archives of gynecology and obstetrics 20090301

• Brain region-specific effects of short-term treatment with duloxetine, venlafaxine, milnacipran and sertraline on monoamine metabolism in rats.

  Neurochemical research 20090301

• Beta2-adrenoceptors are essential for desipramine, venlafaxine or reboxetine action in neuropathic pain.

  Neurobiology of disease 20090301

• Effect of augmented atypical antipsychotics on weight change in patients with major depressive disorder in a naturalistic setting.

  Human psychopharmacology 20090301

• Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response.

  Journal of the American Academy of Child and Adolescent Psychiatry 20090301

• Experience of the use of velaxin (venlafaxine) in anxious depression.

  Neuroscience and behavioral physiology 20090301

• Placebo-controlled inpatient comparison of venlafaxine and fluoxetine for the treatment of major depression with melancholic features.

  International clinical psychopharmacology 20090301

• An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depression.

  The Journal of clinical psychiatry 20090301

• Dose-finding study of fluoxetine and venlafaxine for the treatment of self-injurious and stereotypic behavior in rhesus macaques (Macaca mulatta).

  Journal of the American Association for Laboratory Animal Science : JAALAS 20090301

• Patient preference compared with random allocation in short-term psychodynamic supportive psychotherapy with indicated addition of pharmacotherapy for depression.

  Psychotherapy research : journal of the Society for Psychotherapy Research 20090301

• Optimal dosing of desvenlafaxine, new insights in gambling and anorexia, and caffeine-induced psychosis.

  CNS spectrums 20090301

• An integrated analysis of the efficacy of desvenlafaxine compared with placebo in patients with major depressive disorder.

  CNS spectrums 20090301

• Efficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trial.

  International clinical psychopharmacology 20090301

• The solubility behaviour and thermodynamic relations of the three forms of Venlafaxine free base.

  International journal of pharmaceutics 20090223

• Pilot study of augmentation with aripiprazole for incomplete response in late-life depression: getting to remission.

  The Journal of clinical psychiatry 20090210

• Role of serotonin 5-HT1A receptors in the antidepressant-like effect and the antinociceptive effect of venlafaxine in mice.

  The international journal of neuropsychopharmacology 20090201

• Improvement of psychic and somatic symptoms in adult patients with generalized anxiety disorder: examination from a duloxetine, venlafaxine extended-release and placebo-controlled trial.

  Psychological medicine 20090201

• Onset of activity and time to response on individual CAPS-SX17 items in patients treated for post-traumatic stress disorder with venlafaxine ER: a pooled analysis.

  The international journal of neuropsychopharmacology 20090201

• Venlafaxine-induced excessive yawning.

  Progress in neuro-psychopharmacology & biological psychiatry 20090201

• Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression.

  The American journal of psychiatry 20090201

• Is the antidepressant venlafaxine effective for the treatment of functional dyspepsia?

  Nature clinical practice. Gastroenterology & hepatology 20090201

• Comparison of the pharmacokinetics of venlafaxine extended release and desvenlafaxine in extensive and poor cytochrome P450 2D6 metabolizers.

  Journal of clinical psychopharmacology 20090201

• Case report: Effective treatment of Cotard's syndrome: quetiapine in combination with venlafaxine.

  Psychiatry and clinical neurosciences 20090201

• Is there a correlation between venlafaxine therapy during pregnancy and a higher incidence of necrotizing enterocolitis?

  World journal of pediatrics : WJP 20090201

• Psychosis in the elderly.

  The American journal of psychiatry 20090201

• Automated determination of venlafaxine in human plasma by on-line SPE-LC-MS/MS. Application to a bioequivalence study.

  Journal of separation science 20090201

• Death of a female cocaine user due to the serotonin syndrome following moclobemide-venlafaxine overdose.

  Forensic science international 20090130

• Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.

  Journal of affective disorders 20090101

• [Microscopic colitis associated with celiac disease probably triggered by the administration of venlafaxine].

  La Revue de medecine interne 20090101

• Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine.

  Journal of psychiatric research 20090101

• Newer antidepressants for hot flashes--should their efficacy still be up for debate?

  Menopause (New York, N.Y.) 20090101

• Venlafaxine-induced gynecomastia in a young patient: a case report.

  Clinical neuropharmacology 20090101

• Taurine transporter in lymphocytes of patients with major depression treated with venlafaxine plus psychotherapy.

  Advances in experimental medicine and biology 20090101

• Validation of the Depression and Somatic Symptoms Scale by comparison with the Short Form 36 scale among psychiatric outpatients with major depressive disorder.

  Depression and anxiety 20090101

• Cost effectiveness of venlafaxine compared with generic fluoxetine or generic amitriptyline in major depressive disorder in the UK.

  Clinical drug investigation 20090101

• [Multidrug intoxication].

  Annales de biologie clinique 20090101

• Major depression, antidepressant medication and the risk of obesity.

  Psychotherapy and psychosomatics 20090101

• Comparison of the antidepressant effects of venlafaxine and dosulepin in a naturalistic setting.

  Nordic journal of psychiatry 20090101

• Postpartum depression co-occurring with lactation-related osteoporosis.

  Psychosomatics 20090101

• Acute tamoxifen-induced depression and its prevention with venlafaxine.

  Psychosomatics 20090101

• Early adversity in chronic depression: clinical correlates and response to pharmacotherapy.

  Depression and anxiety 20090101

• [Results of a study of velaxin (venlafaxine) efficacy in patients with subacute and chronic spondylogenic dorsalgia].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20090101

• A single-blind placebo run-in study of venlafaxine XR for activity-limiting osteoarthritis pain.

  Pain medicine (Malden, Mass.) 20090101

• Bruxism possibly induced by venlafaxine.

  Clinical neuropharmacology 20090101

• [Treatment with venlafaxine extended release for climacteric women with depression or anxiety diagnosis. An open-label study].

  Actas espanolas de psiquiatria 20090101

• Akathisia and abnormal movements of the upper extremities with venlafaxine and methimazole.

  General hospital psychiatry 20090101

• Improvement of paradoxical vocal cord dysfunction with integrated psychiatric care.

  Psychosomatics 20090101

• Venlafaxine induced acute myocardial infarction with normal coronary arteries.

  American journal of therapeutics 20090101

• Desvenlafaxine and venlafaxine exert minimal in vitro inhibition of human cytochrome P450 and P-glycoprotein activities.

  Psychopharmacology bulletin 20090101

• Escitalopram and venlafaxine for the prophylaxis of migraine headache without mood disorders.

  Clinical neuropharmacology 20090101

• Are there differences between serotonergic, noradrenergic and dual acting antidepressants in the treatment of depressed women?

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101

• Cortisol metabolism in depressed patients and healthy controls.

  Neuroendocrinology 20090101

• Pharmacotherapy for social anxiety disorder: an update.

  The Israel journal of psychiatry and related sciences 20090101

• Assessing rates and predictors of tachyphylaxis during the prevention of recurrent episodes of depression with venlafaxine ER for two years (PREVENT) study.

  Psychopharmacology bulletin 20090101

• Generalized peripheral nerve hyperexcitability associated with lithium.

  The Journal of neuropsychiatry and clinical neurosciences 20090101

• [Misuse of substances theoretically without abuse potential--case series].

  Przeglad lekarski 20090101

• The treatment of SSRI-resistant depression in adolescents (TORDIA): in search of the best next step.

  Depression and anxiety 20090101

• Venlafaxine-induced hepatotoxicity in a patient with ulcerative colitis.

  Annals of hepatology 20090101

• Advanced formulation design of venlafaxine hydrochloride coated and triple-layer tablets containing hypromellose.

  Pharmaceutical development and technology 20090101

• Longitudinal changes of day-time and night-time gross motor activity in clinical responders and non-responders of major depression.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101

• Neurotrophic factors in serum following ECT: a pilot study.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101

• Pro-inflammatory biomakers in depression: treatment with venlafaxine.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101

• [Evidence-based pharmacoanalytics of using venlafaxine in clinical medicine].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20090101

• Serotonin syndrome in a chronic-pain patient receiving concurrent methadone, ciprofloxacin, and venlafaxine.

  Psychosomatics 20090101

• Influences of chronic venlafaxine, olanzapine and nicotine on the hippocampal and cortical concentrations of brain-derived neurotrophic factor (BDNF).

  Pharmacological reports : PR 20090101

• A role of nitric oxide mechanism involved in the protective effects of venlafaxine in sleep deprivation.

  Behavioural brain research 20081212

• Estimates of serotonin and norepinephrine transporter inhibition in depressed patients treated with paroxetine or venlafaxine.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20081201

• Reduction in the latency of action of antidepressants by 17 beta-estradiol in the forced swimming test.

  Psychopharmacology 20081201

• Predictive factors for generalized seizures after deliberate citalopram overdose.

  British journal of clinical pharmacology 20081201

• Recent NIMH clinical trials and implications for practice.

  Journal of the American Academy of Child and Adolescent Psychiatry 20081201

• Venlafaxine induced-myoclonus in a patient with mixed dementia.

  Arquivos de neuro-psiquiatria 20081201

• Risperidone, an atypical antipsychotic enhances the antidepressant-like effect of venlafaxine or fluoxetine: possible involvement of alpha-2 adrenergic receptors.

  Neuroscience letters 20081107

• Restless legs syndrome as side effect of second generation antidepressants.

  Journal of psychiatric research 20081101

• Differences between daily smokers, chippers, and nonsmokers with co-occurring anxiety and alcohol-use disorders.

  Addictive behaviors 20081101

• Action of (R)-sila-venlafaxine and reboxetine to antagonize cisplatin-induced acute and delayed emesis in the ferret.

  Toxicology and applied pharmacology 20081101

• Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75-225 mg/day in patients with recurrent major depression: a secondary analysis of data from the PREVENT study.

  International clinical psychopharmacology 20081101

• Serotonin toxicity as a consequence of linezolid use in revision hip arthroplasty.

  Orthopedics 20081101

• Stimulus properties of venlafaxine in a conditioned taste aversion procedure.

  European journal of pharmacology 20081031

• [Mood disorders].

  La Revue du praticien 20081031

• Semi-quantitative CYP2D6 gene doses in relation to metabolic ratios of psychotropics.

  European journal of clinical pharmacology 20081001

• Desvenlafaxine: another 'me too' drug?

  The Annals of pharmacotherapy 20081001

• A case of venlafaxine-induced galactorrhea?

  Journal of clinical psychopharmacology 20081001

• Improved insulin sensitivity in 51 nondiabetic depressed inpatients remitting during antidepressive treatment with mirtazapine and venlafaxine.

  Journal of clinical psychopharmacology 20081001

• Treatment of migraine with prophylactic drugs.

  Expert opinion on pharmacotherapy 20081001

• Drug interactions and pharmacogenomics in the treatment of breast cancer and depression.

  The American journal of psychiatry 20081001

• Antidepressant-like effect of 17beta-estradiol: involvement of dopaminergic, serotonergic, and (or) sigma-1 receptor systems.

  Canadian journal of physiology and pharmacology 20081001

• [Hypersensitivity pneumonitis due to venlafaxine].

  Archivos de bronconeumologia 20081001

• Changes in brain function during administration of venlafaxine or placebo to normal subjects.

  Clinical EEG and neuroscience 20081001

• Pharmacoeconomics of antidepressants in moderate-to-severe depressive disorder in Colombia.

  Revista panamericana de salud publica = Pan American journal of public health 20081001

• A pooled analysis of gender and trauma-type effects on responsiveness to treatment of PTSD with venlafaxine extended release or placebo.

  The Journal of clinical psychiatry 20081001

• LC-MS/MS method for the determination of nine antidepressants and some of their main metabolites in oral fluid and plasma. Study of correlation between venlafaxine concentrations in both matrices.

  Journal of pharmaceutical and biomedical analysis 20080910

• Screening of venlafaxine hydrochloride for transdermal delivery: passive diffusion and iontophoresis.

  AAPS PharmSciTech 20080901

• Venlafaxine dependence in a patient with a history of alcohol and amineptine misuse.

  Addiction (Abingdon, England) 20080901

• Determination of venlafaxine in human plasma by high-performance liquid chromatography using cloud-point extraction and spectrofluorimetric detection.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080901

• Efficacy, safety, and tolerability of fixed-dose desvenlafaxine 50 and 100 mg/day for major depressive disorder in a placebo-controlled trial.

  International clinical psychopharmacology 20080901

• Effects of venlafaxine extended release on resilience in posttraumatic stress disorder: an item analysis of the Connor-Davidson Resilience Scale.

  International clinical psychopharmacology 20080901

• [Combining venlafaxine and mirtazapine for the treatment of major depression with dysthymia--'double depression'].

  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20080901

• [A place for SSRIs in the treatment of severely depressed children and adolescents].

  Nederlands tijdschrift voor geneeskunde 20080802

• Early reduction in prefrontal theta QEEG cordance value predicts response to venlafaxine treatment in patients with resistant depressive disorder.

  European psychiatry : the journal of the Association of European Psychiatrists 20080801

• Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features.

  Archives of general psychiatry 20080801

• [Genomical and metabolomical abnormalities in Alzheimer disease and in experimental models].

  Ideggyogyaszati szemle 20080730

• Liquid chromatography tandem mass spectrometry assay for the simultaneous determination of venlafaxine and O-desmethylvenlafaxine in human plasma and its application to a bioequivalence study.

  Journal of pharmaceutical and biomedical analysis 20080715

• [Palinopsia following discontinuation of venlafaxine].

  Psychiatrische Praxis 20080701

• Similar discontinuation symptoms for withdrawal from medium-dose paroxetine and venlafaxine after nine years in the same patient.

  Journal of psychopharmacology (Oxford, England) 20080701

• Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20080701

• The review by Weinmann and colleagues.

  Psychopharmacology 20080701

• A role for nuclear beta-catenin in SNRI antidepressant-induced hippocampal cell proliferation.

  Neuropharmacology 20080701

• Perinatal depression: treatment options and dilemmas.

  Journal of psychiatry & neuroscience : JPN 20080701

• Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents.

  Archives of general psychiatry 20080701

• The effects of venlafaxine on cognitive functions and quantitative EEG in healthy volunteers.

  Pharmacopsychiatry 20080701

• The treatment of major depressive disorders (MDD) in Thailand using escitalopram compared to fluoxetine and venlafaxine: a pharmacoeconomic evaluation.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20080701

• A double blind, placebo-controlled pilot study of galantamine augmentation of antidepressant treatment in older adults with major depression.

  International journal of geriatric psychiatry 20080601

• Venlafaxine reverses chronic fatigue-induced behavioral, biochemical and neurochemical alterations in mice.

  Pharmacology, biochemistry, and behavior 20080601

• Heart failure worsening and exacerbation after venlafaxine and duloxetine therapy.

  The Annals of pharmacotherapy 20080601

• A double-blind comparison of sexual functioning, antidepressant efficacy, and tolerability between agomelatine and venlafaxine XR.

  Journal of clinical psychopharmacology 20080601

• Sustained-release pellets prepared by combination of wax matrices and double-layer coatings for extremely water-soluble drugs.

  Drug development and industrial pharmacy 20080601

• Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder.

  Journal of managed care pharmacy : JMCP 20080601

• Wine and drug evaluations: lessons on making comparisons of noninferiority.

  Journal of psychopharmacology (Oxford, England) 20080601

• Establishing non-inferiority in treatment trials in psychiatry: guidelines from an Expert Consensus Meeting.

  Journal of psychopharmacology (Oxford, England) 20080601

• A non-inferiority comparison of duloxetine and venlafaxine in the treatment of adult patients with generalized anxiety disorder.

  Journal of psychopharmacology (Oxford, England) 20080601

• Adequacy of venlafaxine dose prescribing in major depression and hospital resources implications.

  Journal of psychopharmacology (Oxford, England) 20080601

• [The place of escitalopram in the severe depressive episodes].

  L'Encephale 20080601

• Effects of various antidepressants on serum thyroid hormone levels in patients with major depressive disorder.

  Progress in neuro-psychopharmacology & biological psychiatry 20080515

• Selective publication of antidepressant trials.

  The New England journal of medicine 20080515

• A functional magnetic resonance imaging predictor of treatment response to venlafaxine in generalized anxiety disorder.

  Biological psychiatry 20080501

• Serum concentrations of venlafaxine and its metabolites O-desmethylvenlafaxine and N-desmethylvenlafaxine in heterozygous carriers of the CYP2D6*3, *4 or *5 allele.

  European journal of clinical pharmacology 20080501

• Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

  International clinical psychopharmacology 20080501

• Maintenance therapy to prevent recurrence of depression: summary and implications of the PREVENT study.

  Expert review of neurotherapeutics 20080501

• Duration of untreated illness as a predictor of treatment response and clinical course in generalized anxiety disorder.

  CNS spectrums 20080501

• The effect of rate of antidepressant tapering on the incidence of discontinuation symptoms: a randomised study.

  Journal of psychopharmacology (Oxford, England) 20080501

• [Drug-induced pneumonitis in a patient treated with venlafaxine and propanolol].

  Revue des maladies respiratoires 20080501

• Do new-generation antidepressants work?

  Irish medical journal 20080501

• Does venlafaxine maintenance therapy prevent depression recurrences or drug discontinuation reactions?

  The Journal of clinical psychiatry 20080501

• Hepatic effects of duloxetine-III: analysis of hepatic events using external data sources.

  Current drug safety 20080501

• Inhibition of uptake 2 (or extraneuronal monoamine transporter) by normetanephrine potentiates the neurochemical effects of venlafaxine.

  Brain research 20080408

• Experimental and computational morphology of three polymorphs of the free base of Venlafaxine: a comparison of morphology prediction methods.

  International journal of pharmaceutics 20080402

• Treatment of SSRI-resistant depression: a meta-analysis comparing within- versus across-class switches.

  Biological psychiatry 20080401

• A case series of increased libido and spontaneous orgasm associated with venlafaxine treatment.

  Progress in neuro-psychopharmacology & biological psychiatry 20080401

• The cost-utility of maintenance treatment with venlafaxine in patients with recurrent major depressive disorder.

  International journal of clinical practice 20080401

• Change in pain severity with open label venlafaxine use in patients with a depressive symptomatology: an observational study in primary care.

  European psychiatry : the journal of the Association of European Psychiatrists 20080401

• Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.

  The Australian and New Zealand journal of psychiatry 20080401

• The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.

  Journal of clinical psychopharmacology 20080401

• Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.

  Journal of clinical psychopharmacology 20080401

• Dose-related increase of intraocular pressure caused by venlafaxine use: case report.

  Journal of clinical psychopharmacology 20080401

• Fatal cardiotoxicity induced by venlafaxine overdosage.

  Clinical toxicology (Philadelphia, Pa.) 20080401

• Anticholinergic-type effects following a pediatric venlafaxine overdose.

  Clinical toxicology (Philadelphia, Pa.) 20080401

• Venlafaxine: Successful treatment in impulsive disorders.

  Psychiatry and clinical neurosciences 20080401

• New antidepressants for older people: a critical review of the evidence base.

  L'Encephale 20080401

• Menopausal symptoms following tamoxifen treatment for breast cancer.

  Oncology (Williston Park, N.Y.) 20080401

• Re-evaluation of the efficacy and tolerability of venlafaxine vs SSRI: meta-analysis.

  Psychopharmacology 20080301

• Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report.

  The American journal of psychiatry 20080301

• An investigation of the effect of immediate and extended release venlafaxine on nocturnal melatonin and cortisol release in healthy adult volunteers.

  Human psychopharmacology 20080301

• Hypotension caused by therapeutic doses of venlafaxine: case report and proposed pathophysiological mechanisms.

  Journal of psychopharmacology (Oxford, England) 20080301

• Heparin-immobilized pluronic/PVA composite microparticles for the sustained delivery of ionic drug.

  Journal of microencapsulation 20080301

• Venlafaxine-propafenone interaction resulting in hallucinations and psychomotor agitation.

  The Annals of pharmacotherapy 20080301

• Combined antidepressants and CBT for panic disorder with agoraphobia.

  Journal of psychiatry & neuroscience : JPN 20080301

• A fatal case of venlafaxine overdose.

  Journal of medical toxicology : official journal of the American College of Medical Toxicology 20080301

• Asystole during electroconvulsive therapy in an elderly woman treated concomitantly with venlafaxine.

  The Australian and New Zealand journal of psychiatry 20080301

• Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial.

  JAMA 20080227

• Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs.

  Biological psychiatry 20080215

• Successful duloxetine use to prevent venlafaxine withdrawal symptoms.

  Progress in neuro-psychopharmacology & biological psychiatry 20080215

• A case of extreme paradoxical insomnia responding selectively to electroconvulsive therapy.

  Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20080215

• Venlafaxine exhibits an anti-inflammatory effect in an inflammatory co-culture model.

  The international journal of neuropsychopharmacology 20080201

• [Painful hyperexcitability syndrome with oxaliplatin containing chemotherapy. Clinical features, pathophysiology and therapeutic options].

  Schmerz (Berlin, Germany) 20080201

• Effect of terbinafine and voriconazole on the pharmacokinetics of the antidepressant venlafaxine.

  Clinical pharmacology and therapeutics 20080201

• Antidepressant-like effects of serotonin type-3 antagonist, ondansetron: an investigation in behaviour-based rodent models.

  Behavioural pharmacology 20080201

• Safety and efficacy of venlafaxine in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomised study.

  Andrologia 20080201

• [A clinical challenge. Pragmatic treatment of migraine and concomitant depression].

  Schmerz (Berlin, Germany) 20080201

• An open-label trial of venlafaxine in body dysmorphic disorder.

  CNS spectrums 20080201

• Similar effects of tramadol and venlafaxine in major depressive disorder.

  Southern medical journal 20080201

• Temporal expression of brain-derived neurotrophic factor (BDNF) mRNA in the rat hippocampus after treatment with selective and mixed monoaminergic antidepressants.

  European journal of pharmacology 20080114

• A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.

  Journal of psychiatric research 20080101

• Effects of major depressive disorder and attention-deficit/hyperactivity disorder on the outcome of treatment for cocaine dependence.

  Journal of substance abuse treatment 20080101

• [Gender differences in clinical profile, response and remission of depressive patients treated with venlafaxine extended release].

  Actas espanolas de psiquiatria 20080101

• Effectiveness and safety of venlafaxine extended release in elderly depressed patients.

  Archives of gerontology and geriatrics 20080101

• Uncoupling between noradrenergic and serotonergic neurons as a molecular basis of stable changes in behavior induced by repeated drugs of abuse.

  Biochemical pharmacology 20080101

• Gingival bleeding due to venlafaxine.

  The Annals of pharmacotherapy 20080101

• Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder.

  Depression and anxiety 20080101

• [Hypertrichosis as a possible adverse reaction to selective amine-reuptake inhibitor antidepressants].

  Atencion primaria 20080101

• Pneumonitis related to venlafaxine.

  Psychosomatics 20080101

• [Is it advisable to combine electroconvulsive therapy (ECT) with psychotropics?].

  Tijdschrift voor psychiatrie 20080101

• [Toxicity in overdoses with new antidepressive agents. A survey of records shows different severity symptoms for different agents].

  Lakartidningen 20080101

• A case from the department of neurology.

  The Mount Sinai journal of medicine, New York 20080101

• Time to rehospitalization in patients with major depressive disorder taking venlafaxine or fluoxetine.

  The Journal of clinical psychiatry 20080101

• Venlafaxine versus mirtazapine in the treatment of undifferentiated somatoform disorder: a 12-week prospective, open-label, randomized, parallel-group trial.

  Clinical drug investigation 20080101

• [Agoraphobia: combined treatment and virtual reality. Preliminary results].

  Actas espanolas de psiquiatria 20080101

• The effect of venlafaxine HCl on painful peripheral diabetic neuropathy in patients with type 2 diabetes mellitus.

  Journal of diabetes and its complications 20080101

• [Velaxin (venlafaxine) in the treatment of anxious depression].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20080101

• Serotonin syndrome: a complex but easily avoidable condition.

  General hospital psychiatry 20080101

• [Antidepressants and their onset of action: a major clinical, methodological and pronostical issue].

  L'Encephale 20080101

• [Correction of affective disorders in patients with cochlear-vestibular disturbances of vascular origin].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20080101

• Are SNRIs more effective than SSRIs? A review of the current state of the controversy.

  Psychopharmacology bulletin 20080101

• Adjunctive use of methylphenidate in the treatment of psychotic unipolar depression.

  Clinical neuropharmacology 20080101

• Plasma brain-derived neurotrophic factor as a peripheral marker for the action mechanism of antidepressants.

  Neuropsychobiology 20080101

• Identifying patients at risk of complete nonresponse in the outpatient treatment of depression.

  Psychotherapy and psychosomatics 20080101

• [Hypomania/mania induced by cessation of antidepressant drugs].

  Turk psikiyatri dergisi = Turkish journal of psychiatry 20080101

• Pharmacokinetic/pharmacodynamic modelling of venlafaxine: pupillary light reflex as a test system for noradrenergic effects.

  Clinical pharmacokinetics 20080101

• [ Hot flashes and breast cancer: what to do? ].

  Revista da Associacao Medica Brasileira (1992) 20080101

• The effect of pain on outcomes in a trial of duloxetine treatment of major depressive disorder.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20080101

• Non-fearful panic disorder in gastroenterology.

  Psychosomatics 20080101

• A case of serotonin syndrome associated with methadone overdose.

  Proceedings of the Western Pharmacology Society 20080101

• The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases.

  Biological psychiatry 20071215

• Venlafaxine versus nortriptyline in the treatment of elderly depressed inpatients: a randomised, double-blind, controlled trial.

  International journal of geriatric psychiatry 20071201

• Evaluation of serotonin, noradrenaline and dopamine reuptake inhibitors on light-induced phase advances in hamster circadian activity rhythms.

  Psychopharmacology 20071201

• Venlafaxine to treat severe hypotension.

  Nephrology (Carlton, Vic.) 20071201

• Delivery outcome in relation to maternal use of some recently introduced antidepressants.

  Journal of clinical psychopharmacology 20071201

• The effects of venlafaxine on autonomic functions in healthy volunteers.

  Journal of clinical psychopharmacology 20071201

• Pharmacokinetics and elimination of quetiapine, venlafaxine, and trazodone during pregnancy and postpartum.

  Journal of clinical psychopharmacology 20071201

• Depressed patients perception of the efficacy of electroconvulsive therapy and venlafaxine therapy.

  Neuro endocrinology letters 20071201

• Recurrent herpes and post-traumatic stress disorder.

  Herpes : the journal of the IHMF 20071201

• A Randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder.

  Biological psychiatry 20071115

• A randomized, single-blind, comparison of venlafaxine with paroxetine in elderly patients suffering from resistant depression.

  International clinical psychopharmacology 20071101

• Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors.

  Journal of psychopharmacology (Oxford, England) 20071101

• Managing hot flashes in men being treated for prostate cancer.

  Geriatrics 20071101

• Improvement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: randomized, double-blind comparison with venlafaxine.

  The Journal of clinical psychiatry 20071101

• ['Triple therapy' with warfarin, clopidogrel and acetylsalicylic acid. High risk treatment with unclear benefit].

  Lakartidningen 20071101

• [Use of antidepressants among children and adolescents--did the warnings lead to fewer prescriptions?].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20071018

• Non-pharmacological treatment of psychiatrists in addition to the prescribing of an antidepressant drug.

  European psychiatry : the journal of the Association of European Psychiatrists 20071001

• A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder.

  Psychopharmacology 20071001

• Photodistributed eruptive telangiectasia: an uncommon adverse drug reaction to venlafaxine.

  The British journal of dermatology 20071001

• Venlafaxine-lithium toxicity: suitability for use in the elderly.

  Journal of clinical pharmacy and therapeutics 20071001

• Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.

  The Journal of clinical psychiatry 20071001

• Sertraline versus venlafaxine XR in major depressive disorder.

  The Journal of clinical psychiatry 20071001

• Serotonin transporter occupancy of high-dose selective serotonin reuptake inhibitors during major depressive disorder measured with [11C]DASB positron emission tomography.

  Psychopharmacology 20070901

• Antidepressant use and off-label prescribing in children and adolescents in Dutch general practice (2001-2005).

  Pharmacoepidemiology and drug safety 20070901

• Analysis of the second generation antidepressant venlafaxine and its main active metabolite O-desmethylvenlafaxine in human plasma by HPLC with spectrofluorimetric detection.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070901

• Safety profile of treatment in diabetic peripheral neuropathic pain.

  Pain medicine (Malden, Mass.) 20070901

• Cytochrome P450 2D6 genotype variation and venlafaxine dosage.

  Mayo Clinic proceedings 20070901

• Analysis of the rate of improvement of specific psychic and somatic symptoms of general anxiety disorder during long-term treatment with venlafaxine ER.

  CNS spectrums 20070901

• Gastric bezoar following venlafaxine overdose.

  Clinical toxicology (Philadelphia, Pa.) 20070901

• An abbreviated version of the Connor-Davidson Resilience Scale (CD-RISC), the CD-RISC2: psychometric properties and applications in psychopharmacological trials.

  Psychiatry research 20070830

• Effects of antidepressant treatment on neural correlates of emotional and neutral declarative verbal memory in depression.

  Journal of affective disorders 20070801

• The DRD2 TaqI-B polymorphism and its relationship to smoking abstinence and withdrawal symptoms.

  The pharmacogenomics journal 20070801

• Cardiovascular toxicity due to venlafaxine poisoning in adults: a review of 235 consecutive cases.

  British journal of clinical pharmacology 20070801

• Severe hypoglycemia following venlafaxine intoxication: a case report.

  Journal of clinical psychopharmacology 20070801

• Venlafaxine vs. paroxetine in the acute phase of treatment for major depressive disorder among Han Chinese population in Taiwan.

  Journal of clinical pharmacy and therapeutics 20070801

• Cardiovascular changes associated with venlafaxine in the treatment of late-life depression.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20070801

• Venlafaxine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder.

  Journal of child and adolescent psychopharmacology 20070801

• Lithium augmentation compared with phenelzine in treatment-resistant depression in the elderly: an open, randomized, controlled trial.

  The Journal of clinical psychiatry 20070801

• The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases.

  The Journal of clinical psychiatry 20070801

• Antidepressant response in the elderly.

  Psychiatry research 20070730

• Health-related quality of life and its predictive role for analgesic effect in patients with painful polyneuropathy.

  European journal of pain (London, England) 20070701

• In vivo effect of venlafaxine on locus coeruleus neurons: role of opioid, alpha(2)-adrenergic, and 5-hydroxytryptamine(1A) receptors.

  The Journal of pharmacology and experimental therapeutics 20070701

• Charles Bonnet Syndrome: successful treatment of visual hallucinations due to vision loss with selective serotonin reuptake inhibitors.

  Journal of psychopharmacology (Oxford, England) 20070701

• Treatment of familial erythromelalgia with venlafaxine.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20070701

• Hyperprolactinemia and galactorrhea induced by serotonin and norepinephrine reuptake inhibiting antidepressants.

  The American journal of psychiatry 20070701

• Using psychostimulants for treating residual symptoms in major depression.

  Journal of psychiatry & neuroscience : JPN 20070701

• Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study.

  The Journal of clinical psychiatry 20070701

• [Symptomatic secondary hyponatraemia due to combined treatment anticonvulsant and antidepressant: risk of sudden death in epilepsy?].

  Anales de medicina interna (Madrid, Spain : 1984) 20070701

• Venlafaxine and tardive blepharospasm: a case report.

  Progress in neuro-psychopharmacology & biological psychiatry 20070630

• [Why measure drug metabolites?].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20070628

• Involvement of sigma-1 receptor modulation in the antidepressant action of venlafaxine.

  Neuroscience letters 20070615

• Extended-release venlafaxine-induced alopecia.

  The Annals of pharmacotherapy 20070601

• Extended-release formulation of venlafaxine in the treatment of post-traumatic stress disorder.

  Expert review of neurotherapeutics 20070601

• Venlafaxine efficacy and tolerability in the treatment of post-stroke depression.

  Psychiatria Danubina 20070601

• Involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of venlafaxine in mice.

  Progress in neuro-psychopharmacology & biological psychiatry 20070509

• Simultaneous stereoselective analysis of venlafaxine and O-desmethylvenlafaxine enantiomers in human plasma by HPLC-ESI/MS using a vancomycin chiral column.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070501

• High performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI) method for simultaneous determination of venlafaxine and its three metabolites in human plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070501

• Cerebral volume measurements and subcortical white matter lesions and short-term treatment response in late life depression.

  International journal of geriatric psychiatry 20070501

• Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial.

  International clinical psychopharmacology 20070501

• Venlafaxine hyponatraemia: incidence, mechanism and management.

  The Australian and New Zealand journal of psychiatry 20070501

• Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report.

  The American journal of psychiatry 20070501

• Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial.

  The American journal of psychiatry 20070501

• Prediction of response to paroxetine and venlafaxine by serotonin-related genes in obsessive-compulsive disorder in a randomized, double-blind trial.

  The Journal of clinical psychiatry 20070501

• Validation and application of a stability-indicating HPLC method for the in vitro determination of gastric and intestinal stability of venlafaxine.

  Journal of pharmaceutical and biomedical analysis 20070411

• Is it possible to predict the long-term response to venlafaxine with the use of biological markers and psychophysiological methods?

  Journal of affective disorders 20070401

• Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients--a double-blind, randomized study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070401

• A randomized, double-blind, placebo-controlled study of venlafaxine XR in out-patients with tension-type headache.

  Cephalalgia : an international journal of headache 20070401

• Using striatal dopamine transporter single photon emission computed tomography imaging to rule out Dementia with Lewy Bodies in elderly patients with antipsychotic-induced parkinsonism.

  Psychiatry and clinical neurosciences 20070401

• Escitalopram in the treatment of major depressive disorder: clinical efficacy, tolerability and cost-effectiveness vs. venlafaxine extended-release formulation.

  International journal of clinical practice 20070401

• Cardiovascular effects of high dose venlafaxine XL in patients with major depressive disorder.

  Human psychopharmacology 20070401

• STAR*D level IV methodology.

  The American journal of psychiatry 20070401

• An open-label trial of aripiprazole augmentation for treatment-resistant generalized anxiety disorder.

  Journal of clinical psychopharmacology 20070401

• Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials.

  Journal of the American Academy of Child and Adolescent Psychiatry 20070401

• Data safety monitoring boards and other study methodologies that address subject safety in 'high-risk' therapeutic trials in youths.

  Journal of the American Academy of Child and Adolescent Psychiatry 20070401

• Treatment of narcolepsy with cataplexy.

  Lancet (London, England) 20070331

• Liquid chromatography-mass spectrometry method for the determination of venlafaxine in human plasma and application to a pharmacokinetic study.

  Biomedical chromatography : BMC 20070301

• Venlafaxine modulates depression-induced oxidative stress in brain and medulla of rat.

  Neurochemical research 20070301

• Venlafaxine-mirtazapine combination in the treatment of persistent depressive illness.

  Journal of psychopharmacology (Oxford, England) 20070301

• Long-term, open-label venlafaxine extended-release treatment in children and adolescents with major depressive disorder.

  CNS spectrums 20070301

• Onset of confusion in the context of late-life depression.

  Journal of psychiatry & neuroscience : JPN 20070301

• Was the exacerbation of PTSD symptoms after high doses of venlafaxine due to the noradrenergic mechanism? A case report.

  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20070301

• Evolving epidemiology of drug-induced seizures reported to a Poison Control Center System.

  Journal of medical toxicology : official journal of the American College of Medical Toxicology 20070301

• Dopaminergic function in depressed patients with affective flattening or with impulsivity: [18F]fluoro-L-dopa positron emission tomography study with voxel-based analysis.

  Psychiatry research 20070227

• Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study.

  BMJ (Clinical research ed.) 20070203

• Venlafaxine for major depression.

  BMJ (Clinical research ed.) 20070203

• Discontinuation symptoms in depression and anxiety disorders.

  The international journal of neuropsychopharmacology 20070201

• Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers.

  The international journal of neuropsychopharmacology 20070201

• Differential physiological effects of a low dose and high doses of venlafaxine in major depression.

  The international journal of neuropsychopharmacology 20070201

• Displacement of serotonin and dopamine transporters by venlafaxine extended release capsule at steady state: a [123I]2beta-carbomethoxy-3beta-(4-iodophenyl)-tropane single photon emission computed tomography imaging study.

  Journal of clinical psychopharmacology 20070201

• Venlafaxine discontinuation syndrome and suicidal ideation: a case series.

  Journal of clinical psychopharmacology 20070201

• STAR*D: what have we learned?

  The American journal of psychiatry 20070201

• Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials.

  The American journal of psychiatry 20070201

• Serotonin syndrome precipitated by the monoamine oxidase inhibitor linezolid.

  The American journal of psychiatry 20070201

• False positive phencyclidine results caused by venlafaxine.

  The American journal of psychiatry 20070201

• Acute heart failure associated with venlafaxine poisoning.

  The American journal of emergency medicine 20070201

• Mania after venlafaxine withdrawal in a patient with generalized anxiety disorder.

  The Annals of pharmacotherapy 20070201

• Alternate venlafaxine kinetics in overdose patients.

  Journal of clinical pharmacy and therapeutics 20070201

• Venlafaxine ingestion is associated with rhabdomyolysis in adults: a case series.

  The Journal of toxicological sciences 20070201

• Venlafaxine (Effexor): concerns about increased risk of fatal outcomes in overdose.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20070102

• A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.

  Journal of psychiatric research 20070101

• Electrical alternans and hemodynamics in the anesthetized guinea pig can discriminate the cardiac safety of antidepressants.

  Journal of pharmacological and toxicological methods 20070101

• Validation of a Dutch translation of the fibromyalgia impact questionnaire.

  Rheumatology (Oxford, England) 20070101

• A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.

  Depression and anxiety 20070101

• Pharmacokinetic/pharmacodynamic modelling of cardiac toxicity in venlafaxine overdose.

  Intensive care medicine 20070101

• Persistent sexual arousal syndrome: a case report and review of the literature.

  Journal of sex & marital therapy 20070101

• Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: a randomized, placebo-controlled pilot study.

  Depression and anxiety 20070101

• Syndrome of inappropriate secretion of antidiuretic hormone due to citalopram and venlafaxine.

  General hospital psychiatry 20070101

• Venlafaxine induces P-glycoprotein in human Caco-2 cells.

  Human psychopharmacology 20070101

• Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment-resistant depression.

  Human psychopharmacology 20070101

• Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates.

  Pediatrics 20070101

• Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer.

  The oncologist 20070101

• Relapse prevention of panic disorder in adult outpatient responders to treatment with venlafaxine extended release.

  The Journal of clinical psychiatry 20070101

• Current approaches to the pharmacologic treatment of anxiety disorders.

  Psychopharmacology bulletin 20070101

• A Danish cost-effectiveness model of escitalopram in comparison with citalopram and venlafaxine as first-line treatments for major depressive disorder in primary care.

  Nordic journal of psychiatry 20070101

• Employing atmospheric pressure photoionization in liquid chromatography/tandem mass spectrometry to minimize ion suppression and matrix effects for the quantification of venlafaxine and O-desmethylvenlafaxine.

  Rapid communications in mass spectrometry : RCM 20070101

• A placebo-controlled double-blind randomized study of venlafaxine in the treatment of depression in dementia.

  Dementia and geriatric cognitive disorders 20070101

• [Applications and safety of modern antidepressants in patients with liver diseases].

  Wiadomosci lekarskie (Warsaw, Poland : 1960) 20070101

• Effect of addition of yohimbine (alpha-2-receptor antagonist) to the antidepressant activity of fluoxetine or venlafaxine in the mouse forced swim test.

  Pharmacology 20070101

• [Malignant neuroleptic syndrome and serotoninergic syndrome: two cases].

  Revista clinica espanola 20070101

• [Venlafaxine extended release and alcohol dependence].

  Adicciones 20070101

• The redistribution of selected psychiatric drugs in post-mortem cases.

  Forensic science international 20061220

• Digitalis intoxication induced by paroxetine co-administration.

  Lancet (London, England) 20061202

• Venlafaxine-induced ecchymoses and impaired platelet aggregation.

  European journal of haematology 20061201

• Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: evidence for synergism between serotonergic and noradrenergic reuptake inhibition.

  Neuropharmacology 20061201

• Delirium associated with concomitant use of low-dose bupropion sustained release and fluoxetine.

  Journal of clinical psychopharmacology 20061201

• Bezoar formation requiring endoscopic removal after intentional overdose of extended-release nifedipine.

  Pharmacotherapy 20061201

• Beyond remission: rationale and design of the Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study.

  CNS spectrums 20061201

• Simultaneous separation and determination of process-related substances and degradation products of venlafaxine by reversed-phase HPLC.

  Journal of separation science 20061201

• Early response to venlafaxine antidepressant correlates with lower ACTH levels prior to pharmacological treatment.

  Endocrine 20061201

• Neonatal seizures from in utero venlafaxine exposure.

  Journal of paediatrics and child health 20061101

• Venlafaxine for treatment of interferon alfa-induced depression.

  The Annals of pharmacotherapy 20061101

• Prescribing of venlafaxine and dosulepin in primary care.

  Journal of psychopharmacology (Oxford, England) 20061101

• Using meta-regression in performing indirect-comparisons: comparing escitalopram with venlafaxine XR.

  Current medical research and opinion 20061101

• A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder.

  The Journal of clinical psychiatry 20061101

• Dose-dependent Venlafaxine-induced sinus tachycardia.

  International journal of cardiology 20061026

• Antidepressant withdrawal symptoms-telephone calls to a national medication helpline.

  Journal of affective disorders 20061001

• CYP2D6 polymorphism and clinical effect of the antidepressant venlafaxine.

  Journal of clinical pharmacy and therapeutics 20061001

• A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability.

  Journal of clinical psychopharmacology 20061001

• Quetiapine augmentation in lactation: a series of case reports.

  Journal of clinical psychopharmacology 20061001

• NICE guidelines on antidepressants.

  The British journal of general practice : the journal of the Royal College of General Practitioners 20061001

• Defining response and remission in anxiety disorders: toward an integrated approach.

  CNS spectrums 20061001

• Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial.

  Archives of general psychiatry 20061001

• A comparison of the efficacy and tolerability of reboxetine and sertraline versus venlafaxine in major depressive disorder: a randomized, open-labeled clinical trial.

  Progress in neuro-psychopharmacology & biological psychiatry 20060930

• [Social anxiety disorders].

  Der Nervenarzt 20060901

• Kava in generalized anxiety disorder: three placebo-controlled trials.

  International clinical psychopharmacology 20060901

• Escitalopram versus venlafaxine XR in the treatment of depression.

  International clinical psychopharmacology 20060901

• Acute adverse cutaneous reaction after the concomitant use of venlafaxine and orphenadrine citrate plus paracetamol in a depressed patient.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20060901

• Cardiovascular changes associated with venlafaxine in the treatment of late-life depression.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20060901

• Volte-face on venlafaxine--reasons and reflections.

  Journal of psychopharmacology (Oxford, England) 20060901

• Keeping our eyes on STAR*D.

  The American journal of psychiatry 20060901

• Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.

  The American journal of psychiatry 20060901

• Less mood switching with venlafaxine?

  The American journal of psychiatry 20060901

• Enantioselective synthesis of beta-amino esters and its application to the synthesis of the enantiomers of the antidepressant Venlafaxine.

  Chemical communications (Cambridge, England) 20060807

• Chronic administration of venlafaxine fails to attenuate 5-HT1A receptor function at the level of receptor-G protein interaction.

  The international journal of neuropsychopharmacology 20060801

• Difference in pre- and post-treatment plasma DHEA levels were significantly and positively correlated with difference in pre- and post-treatment Hamilton depression scores following successful therapy for major depression.

  Psychoneuroendocrinology 20060801

• The role of IL-12 and TGF-beta1 in the pathophysiology of major depressive disorder.

  International immunopharmacology 20060801

• Venlafaxine compromises the antinociceptive actions of gabapentin in rat models of neuropathic and persistent pain.

  Psychopharmacology 20060801

• A case of recurrent hyponatremia induced by venlafaxine.

  Journal of clinical psychopharmacology 20060801

• Changes in brain function (quantitative EEG cordance) during placebo lead-in and treatment outcomes in clinical trials for major depression.

  The American journal of psychiatry 20060801

• Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline.

  The British journal of psychiatry : the journal of mental science 20060801

• Lithium and venlafaxine interaction: a case of serotonin syndrome.

  Journal of clinical pharmacy and therapeutics 20060801

• Aripiprazole augmentation of venlafaxine in the treatment of psychogenic excoriation.

  The Journal of clinical psychiatry 20060801

• Linezolid and serotonergic drug interactions: a retrospective survey.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060715

• Repetitive transcranial magnetic stimulation (rTMS) in a patient suffering from comorbid depression and panic disorder following a myocardial infarction.

  Progress in neuro-psychopharmacology & biological psychiatry 20060701

• Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: an open label study.

  Human psychopharmacology 20060701

• Lamotrigine-associated anticonvulsant hypersensitivity syndrome in bipolar disorder.

  Progress in neuro-psychopharmacology & biological psychiatry 20060601

• CYP2D6 genotype and venlafaxine-XR concentrations in depressed elderly.

  International journal of geriatric psychiatry 20060601

• Treatment with venlafaxine extended release after SSRI nonresponse or intolerance: a randomized comparison of standard- and higher-dosing strategies.

  Journal of clinical psychopharmacology 20060601

• Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study.

  Journal of clinical psychopharmacology 20060601

• Comparison of venlafaxine extended release versus paroxetine for treatment of patients with generalized anxiety disorder.

  Psychiatry and clinical neurosciences 20060601

• Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain.

  The journal of pain : official journal of the American Pain Society 20060601

• [Trazodone for the treatment of behavioral and psychological symptoms of dementia (BPSD) in Alzheimer's disease: a retrospective study focused on the aggression and negativism in caregiving situations].

  No to shinkei = Brain and nerve 20060601

• Depression in adults.

  Clinical evidence 20060601

• Narcolepsy-cataplexy associated with precocious puberty.

  Neurology 20060523

• [Anxiety disorders: diagnosis and therapy from the family physician's perspective].

  MMW Fortschritte der Medizin 20060515

• Optimization of the separation of some psychotropic drugs and their respective metabolites by liquid chromatography.

  Journal of pharmaceutical and biomedical analysis 20060503

• (R)-sila-venlafaxine: a selective noradrenaline reuptake inhibitor for the treatment of emesis.

  Bioorganic & medicinal chemistry letters 20060501

• Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application.

  Pharmacology & therapeutics 20060501

• Microsphere-based protease assays and screening application for lethal factor and factor Xa.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

• Venlafaxine-associated psoriasiform palmoplantar keratoderma and subungual hyperkeratosis.

  The British journal of dermatology 20060501

• Biological perspectives. Serotonin and norepinephrine reuptake inhibitors (SNRIs): venlafaxine and duloxetine.

  Perspectives in psychiatric care 20060501

• Lamotrigine add-on therapy to venlafaxine treatment in adolescent-onset bipolar II disorder: a case report covering an 8-month observation period.

  International journal of clinical pharmacology and therapeutics 20060501

• Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine.

  The Journal of clinical psychiatry 20060501

• QT interval prolongation associated with venlafaxine administration.

  International journal of cardiology 20060428

• [Not neglecting therapy of depression in the elderly].

  MMW Fortschritte der Medizin 20060420

• Effects of paroxetine and venlafaxine on immune parameters in patients with obsessive compulsive disorder.

  Psychoneuroendocrinology 20060401

• Synthesis of new bioactive venlafaxine analogs: novel thiazolidin-4-ones as antimicrobials.

  Bioorganic & medicinal chemistry 20060401

• Venlafaxine extended-release in patients older than 80 years with depressive syndrome.

  International journal of geriatric psychiatry 20060401

• A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20060401

• Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review.

  The Journal of clinical psychiatry 20060401

• The influence of tobacco smoke and nicotine on antidepressant and memory-improving effects of venlafaxine.

  Human & experimental toxicology 20060401

• Can venlafaxine in breast milk attenuate the norepinephrine and serotonin reuptake neonatal withdrawal syndrome.

  Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 20060401

• [Psychotherapies: what is the impact on the cortical and subcortical levels?].

  L'Encephale 20060401

• Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

  The New England journal of medicine 20060323

• Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060320

• A comparison of the chronic treatment effects of venlafaxine and other antidepressants on serotonin and norepinephrine transporters.

  Biological psychiatry 20060301

• Low-dose venlafaxine in three adolescents and young adults with autistic disorder improves self-injurious behavior and attention deficit/hyperactivity disorders (ADHD)-like symptoms.

  Progress in neuro-psychopharmacology & biological psychiatry 20060301

• Tension-type headache with aura.

  Cephalalgia : an international journal of headache 20060301

• Managing depressive and anxiety disorders with escitalopram.

  Expert opinion on pharmacotherapy 20060301

• Noradrenergic and serotonergic modulation to treat vasomotor symptoms.

  The journal of the British Menopause Society 20060301

• Treatment of anxiety disorders with venlafaxine XR.

  Expert review of neurotherapeutics 20060301

• Estimation of symptom-free days in generalized anxiety disorder.

  Current medical research and opinion 20060301

• Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.

  Journal of psychiatry & neuroscience : JPN 20060301

• Treatment guidelines for mania.

  Journal of psychiatry & neuroscience : JPN 20060301

• Anesthesiologist suicide with atracurium.

  Journal of analytical toxicology 20060301

• Effects of venlafaxine and desipramine on heroin-induced conditioned place preference in the rat.

  Addiction biology 20060301

• Menopausal symptoms after cessation of hormone replacement therapy.

  Maturitas 20060220

• Serotonin transporter residual availability during long-term antidepressant therapy does not differentiate responder and nonresponder unipolar patients.

  Biological psychiatry 20060215

• Mirtazapine orally disintegrating tablets versus venlafaxine extended release: a double-blind, randomized multicenter trial comparing the onset of antidepressant response in patients with major depressive disorder.

  Journal of clinical psychopharmacology 20060201

• Venlafaxine and the rapid development of anasarca.

  Journal of clinical psychopharmacology 20060201

• Hepatitis associated with low-dose venlafaxine for postmenopausal vasomotor symptoms.

  The Annals of pharmacotherapy 20060201

• Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain.

  Journal of palliative medicine 20060201

• Atomoxetine enhances a short-term model of plasticity in humans.

  Archives of physical medicine and rehabilitation 20060201

• Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers.

  The American journal of psychiatry 20060201

• Role of the opioidergic system and nitric oxide in the analgesic effect of venlafaxine.

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20060201

• Venlafaxine-associated serotonin syndrome and manic episode in a geriatric depressive patient.

  Psychiatry and clinical neurosciences 20060201

• Electroencephalographic abnormalities associated with antidepressant treatment: a comparison of mirtazapine, venlafaxine, citalopram, reboxetine, and amitriptyline.

  The Journal of clinical psychiatry 20060201

• Induction of neuroserpin expression in rat frontal cortex after chronic antidepressant treatment and electroconvulsive treatment.

  Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20060201

• Simultaneous bilateral acute angle closure glaucoma following venlafaxine treatment.

  Eye (London, England) 20060101

• Discriminative stimulus properties of tianeptine.

  Psychopharmacology 20060101

• Oxcarbazepine-induced thrombocytopenia.

  Psychosomatics 20060101

• Assessment of Canadian provincial expenditures in depressed patients treated with venlafaxine XR versus SSRIs: the APEX Study.

  Current medical research and opinion 20060101

• Venlafaxine extended release in the short-term treatment of depressed and anxious primary care patients with multisomatoform disorder.

  The Journal of clinical psychiatry 20060101

• Neuroleptic malignant syndrome after the use of venlafaxine in a patient with generalized anxiety disorder.

  Journal of the Formosan Medical Association = Taiwan yi zhi 20060101

• Interaction between venlafaxine and caffeine on antinociception in mice.

  Die Pharmazie 20060101

• Interference by venlafaxine ingestion in the detection of tramadol by liquid chromatography linked to tandem mass spectrometry for the screening of illicit drugs in human urine.

  Clinical toxicology (Philadelphia, Pa.) 20060101

• Androgens and menopause: more fuel for the fire.

  Menopause (New York, N.Y.) 20060101

• Efficacy of hormone therapy with and without methyltestosterone augmentation of venlafaxine in the treatment of postmenopausal depression: a double-blind controlled pilot study.

  Menopause (New York, N.Y.) 20060101

• Synergetic effects of quetiapine and venlafaxine in preventing the chronic restraint stress-induced decrease in cell proliferation and BDNF expression in rat hippocampus.

  Hippocampus 20060101

• A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression.

  Depression and anxiety 20060101

• Dementia with mood symptoms in a fragile X premutation carrier with the fragile X-associated tremor/ataxia syndrome: clinical intervention with donepezil and venlafaxine.

  The Journal of neuropsychiatry and clinical neurosciences 20060101

• Modafinil-induced reversible hyperkinetic nondystonic movement disorder in a patient with major depressive disorder.

  The Journal of neuropsychiatry and clinical neurosciences 20060101

• [Effectiveness of venlafaxine extended release and conventional antidepressants in elderly patients with depressive disorder].

  Actas espanolas de psiquiatria 20060101

• [Response and remission in depressive patients with anxiety symptoms treated with venlafaxine extended release in primary care].

  Actas espanolas de psiquiatria 20060101

• [Cost-effectiveness of venlafaxine for the treatment of depression and anxiety. Bibliographic review].

  Actas espanolas de psiquiatria 20060101

• [Ziprasidone as coadjuvant treatment in resistant obsessive-compulsive disorder treatment].

  Actas espanolas de psiquiatria 20060101

• Duloxetine compared with fluoxetine and venlafaxine: use of meta-regression analysis for indirect comparisons.

  BMC psychiatry 20060101

• Substance use disorder comorbidity in major depressive disorder: a confirmatory analysis of the STAR*D cohort.

  The American journal on addictions 20060101

• Spectrophotometric determination of certain antidepressants in pharmaceutical preparations.

  Journal of AOAC International 20060101

• [Unipolar depression suddenly switches to hypomania in a patient who has just started taking venlafaxine].

  Tijdschrift voor psychiatrie 20060101

• Topiramate use in alprazolam addiction.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20060101

• [Primary Human Immunodeficiency Virus infection revealed by psychiatric symptoms].

  L'Encephale 20060101

• Cardioversion of persistent atrial arrhythmia after treatment with venlafaxine in successful management of major depression and posttraumatic stress disorder.

  Psychosomatics 20060101

• Cytotoxicity of different selective serotonin reuptake inhibitors (SSRIs) against cancer cells.

  Journal of experimental therapeutics & oncology 20060101

• Manic switch and serotonin syndrome with venlafaxine-lithium-valproate association.

  Therapie 20060101

• Tolerability of amine uptake inhibitors in urologic diseases.

  Current drug safety 20060101

• The serotonin/noradrenaline reuptake inhibitor venlafaxine attenuates acquisition, but not maintenance, of intravenous self-administration of heroin in rats.

  European journal of pharmacology 20051228

• Liquid chromatography-tandem mass spectrometry (LC-MS-MS) method for simultaneous determination of venlafaxine and its active metabolite O-desmethyl venlafaxine in human plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20051227

• Quetiapine and venlafaxine synergically regulate heme oxygenase-2 protein expression in the hippocampus of stressed rats.

  Neuroscience letters 20051209

• Cost-effectiveness of outpatient treatment in depressive patients with escitalopram in Germany.

  The European journal of health economics : HEPAC : health economics in prevention and care 20051201

• An open-label study of duloxetine for the treatment of major depressive disorder: comparison of switching versus initiating treatment approaches.

  Journal of clinical psychopharmacology 20051201

• Moving beyond balance for a better antidepressant.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20051201

• Fatal venlafaxine overdose with acinar zone 3 liver cell necrosis.

  The American journal of forensic medicine and pathology 20051201

• Development and validation of a flow-injection assay for dissolution studies of the anti-depressant drug venlafaxine.

  Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20051201

• Antidepressant treatment outcomes of psychogenic movement disorder.

  The Journal of clinical psychiatry 20051201

• Does rTMS hasten the response to escitalopram, sertraline, or venlafaxine in patients with major depressive disorder? A double-blind, randomized, sham-controlled trial.

  The Journal of clinical psychiatry 20051201

• Prefrontal GABA levels in cocaine-dependent subjects increase with pramipexole and venlafaxine treatment.

  Psychopharmacology 20051101

• Duloxetine and venlafaxine-XR in the treatment of major depressive disorder: a meta-analysis of randomized clinical trials.

  The Annals of pharmacotherapy 20051101

• Impact of venlafaxine on gene expression profile in lymphocytes of the elderly with major depression--evolution of antidepressants and the role of the 'neuro-immune' system.

  Neurochemical research 20051101

• Combined effects of venlafaxine, nicotine replacement, and brief counseling on smoking cessation.

  Experimental and clinical psychopharmacology 20051101

• Re: Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20051101

• alpha2-Adrenergic agonists antagonise the anxiolytic-like effect of antidepressants in the four-plate test in mice.

  Behavioural brain research 20051014

• Effects of paroxetine and venlafaxine XR on heart rate variability in depression.

  Journal of clinical psychopharmacology 20051001

• Severe rhabdomyolysis following venlafaxine overdose.

  Therapeutic drug monitoring 20051001

• Venlafaxine extended-release capsules in panic disorder: flexible-dose, double-blind, placebo-controlled study.

  The British journal of psychiatry : the journal of mental science 20051001

• Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine.

  Journal of palliative medicine 20051001

• Randomized trial of sertraline versus venlafaxine XR in major depression: efficacy and discontinuation symptoms.

  The Journal of clinical psychiatry 20051001

• Evaluation of antinociceptive and anti-inflammatory effects of venlafaxine in the rat.

  Agri : Agri (Algoloji) Dernegi'nin Yayin organidir = The journal of the Turkish Society of Algology 20051001

• [Love, humor and psychosis in an atypical depression].

  L'Encephale 20051001

• [Cannabis dependence and social phobia].

  L'Encephale 20051001

• Evaluation of low-dose venlafaxine hydrochloride for the therapy of hot flushes in breast cancer survivors.

  Maturitas 20050916

• Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism.

  Bioorganic & medicinal chemistry letters 20050915

• Open-field behavioural alterations in liver-impaired and sham-operated rats after acute exposure to the antidepressant venlafaxine.

  Basic & clinical pharmacology & toxicology 20050901

• SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants.

  CNS spectrums 20050901

• Relative antidepressant efficacy of venlafaxine and SSRIs: sex-age interactions.

  Journal of women's health (2002) 20050901

• Serotonin syndrome and rhabdomyolysis in venlafaxine poisoning: a case report.

  The Netherlands journal of medicine 20050901

• Behavior therapy augments response of patients with obsessive-compulsive disorder responding to drug treatment.

  The Journal of clinical psychiatry 20050901

• [1+1 or 2x1? Another form of dual antidepressive mechanism of action].

  Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20050901

• Detective work: reading fine print, insurers question studies of drugs; Kaiser's veteran sleuth scours medical-journal articles and sees marketing spin; doctors fear loss of choices.

  Wall Street journal (Eastern ed.) 20050824

• The effect of venlafaxine on ongoing and experimentally induced pain in neuropathic pain patients: a double blind, placebo controlled study.

  European journal of pain (London, England) 20050801

• Metabolic ratios of psychotropics as indication of cytochrome P450 2D6/2C19 genotype.

  Therapeutic drug monitoring 20050801

• Cost effectiveness of duloxetine compared with venlafaxine-XR in the treatment of major depressive disorder.

  Current medical research and opinion 20050801

• Venlafaxine XR demonstrates higher rates of sustained remission compared to fluoxetine, paroxetine or placebo.

  International clinical psychopharmacology 20050701

• Olanzapine plus venlafaxine in treatment-resistant depression.

  Journal of psychopharmacology (Oxford, England) 20050701

• Rapid screening of selective serotonin re-uptake inhibitors in urine samples using solid-phase microextraction gas chromatography-mass spectrometry.

  Analytical and bioanalytical chemistry 20050701

• The serotonin syndrome.

  The New England journal of medicine 20050609

• Simultaneous determination of fluoxetine, citalopram, paroxetine, venlafaxine in plasma by high performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI).

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050605

• Cost-effectiveness of venlafaxine XL compared with diazepam in the treatment of generalised anxiety disorder in the United Kingdom.

  The European journal of health economics : HEPAC : health economics in prevention and care 20050601

• Clinical activity of venlafaxine and topiramate against oxaliplatin-induced disabling permanent neuropathy.

  Anti-cancer drugs 20050601

• Prevalence of risk factors for suicide in patients prescribed venlafaxine, fluoxetine, and citalopram.

  Pharmacoepidemiology and drug safety 20050601

• Transient narcolepsy-cataplexy syndrome after discontinuation of the antidepressant venlafaxine.

  Journal of sleep research 20050601

• The four-plates test-retest paradigm to discriminate anxiolytic effects.

  Psychopharmacology 20050601

• Causal or casual?

  Pharmacoepidemiology and drug safety 20050601

• Toxicity with selective serotonin reuptake inhibitors.

  The American journal of psychiatry 20050601

• Dual reuptake inhibitors incur lower rates of tachyphylaxis than selective serotonin reuptake inhibitors: a retrospective study.

  The Journal of clinical psychiatry 20050601

• [Depression in Hashimoto's encephalopathy. Successful treatment of a severe depressive episode with a glucocorticoid as an add-on therapy].

  Der Nervenarzt 20050501

• Chronic administration of the SSRI fluvoxamine markedly and selectively reduces the sensitivity of cortical serotonergic neurons to footshock stress.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20050501

• Implication of 5-HT2 receptor subtypes in the mechanism of action of antidepressants in the four plates test.

  Psychopharmacology 20050501

• Serotonin toxicity associated with concomitant use of linezolid.

  The Annals of pharmacotherapy 20050501

• Clinical experience with venlafaxine in the treatment of hot flushes in women with a history of breast cancer.

  The Netherlands journal of medicine 20050501

• Serotonin syndrome:case report and current concepts.

  Irish medical journal 20050501

• [Trazodone and venlafaxine in treatment of depressive disorders].

  Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20050501

• Neurophysiologic correlates of side effects in normal subjects randomized to venlafaxine or placebo.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20050401

• Increased libido with the combined use of venlafaxine and mirtazapine.

  Journal of clinical psychopharmacology 20050401

• Spinal 5-HT1A receptors differentially influence nociceptive processing according to the nature of the noxious stimulus in rats: effect of WAY-100635 on the antinociceptive activities of paracetamol, venlafaxine and 5-HT.

  Pain 20050401

• Do venlafaxine XR and paroxetine equally influence negative and positive affect?

  Journal of affective disorders 20050401

• Relationship of white matter hyperintensities to cerebrospinal fluid glucose polyol pathway metabolites-a pilot study in treatment-resistant affective disorder patients.

  Journal of affective disorders 20050401

• A probabilistic cost-effectiveness analysis of escitalopram, generic citalopram and venlafaxine as a first-line treatment of major depressive disorder in the UK.

  Current medical research and opinion 20050401

• Venlafaxine-associated interstitial pneumonitis.

  Pharmacotherapy 20050401

• Effects of extract of Ginkgo biloba with venlafaxine on brain injury in a rat model of depression.

  Chinese medical journal 20050305

• Medication-associated somnambulism.

  Journal of the American Academy of Child and Adolescent Psychiatry 20050301

• Fatal cerebral edema after moderate valproic acid overdose.

  Annals of emergency medicine 20050301

• Discontinuation rates for selective serotonin reuptake inhibitors and other second-generation antidepressants in outpatients with major depressive disorder: a systematic review and meta-analysis.

  International clinical psychopharmacology 20050301

• Efficacy screening trials of paroxetine, pentoxifylline, riluzole, pramipexole and venlafaxine in cocaine dependence.

  Addiction (Abingdon, England) 20050301

• Using metaanalysis to evaluate evidence: practical tips and traps.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20050301

• Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20050301

• The efficacy of antidepressants for generalized anxiety disorder: a systematic review and meta-analysis.

  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20050301

• Bilateral acute angle closure caused by supraciliary effusions associated with venlafaxine intake.

  The Medical journal of Australia 20050207

• Venlafaxine, serotonin syndrome, and differential diagnoses.

  Journal of clinical psychopharmacology 20050201

• Venlafaxine extended release for the treatment of patients with premature ejaculation: a pilot, single-blind, placebo-controlled, fixed-dose crossover study on short-term administration of an antidepressant drug.

  International journal of andrology 20050201

• Bupropion and venlafaxine responders differ in pretreatment regional cerebral metabolism in unipolar depression.

  Biological psychiatry 20050201

• The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study.

  Progress in neuro-psychopharmacology & biological psychiatry 20050201

• Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder.

  Archives of general psychiatry 20050201

• A randomized controlled trial of venlafaxine extended release in generalized social anxiety disorder.

  The Journal of clinical psychiatry 20050201

• The efficacy and safety of venlafaxine in the prophylaxis of migraine.

  Headache 20050201

• Adolescents' response to antidepressant treatment in a community mental health center.

  Community mental health journal 20050201

• CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment.

  Journal of the National Cancer Institute 20050105

• Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial.

  Psychopharmacology 20050101

• Trazodone addition for insomnia in venlafaxine-treated, depressed inpatients: a semi-naturalistic study.

  Pharmacological research 20050101

• Extended release of a novel antidepressant, venlafaxine, based on anionic polyamidoamine dendrimers and poly(ethylene glycol)-containing semi-interpenetrating networks.

  Journal of biomedical materials research. Part A 20050101

• Multiple complications and withdrawal syndrome associated with quetiapine/venlafaxine intoxication.

  The Annals of pharmacotherapy 20050101

• The role of venlafaxine in the treatment of obsessive-compulsive disorder.

  The Annals of pharmacotherapy 20050101

• Mirtazapine and venlafaxine in the management of collateral psychopathology during alcohol detoxification.

  Progress in neuro-psychopharmacology & biological psychiatry 20050101

• The prevention of post-surgical neuralgia.

  Pain 20050101

• Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial.

  Obstetrics and gynecology 20050101

• Combined antidepressant and hormone treatment is effective for chemotherapy-induced menopausal syndrome.

  European psychiatry : the journal of the Association of European Psychiatrists 20050101

• [Effectiveness of venlafaxine in the treatment of alcohol dependence with comorbid depression].

  Actas espanolas de psiquiatria 20050101

• Substance use disorder comorbidity in major depressive disorder: an exploratory analysis of the Sequenced Treatment Alternatives to Relieve Depression cohort.

  Comprehensive psychiatry 20050101

• Evaluation of the cost effectiveness of escitalopram versus venlafaxine XR in major depressive disorder.

  PharmacoEconomics 20050101

• Capgras syndrome in the modern era: self misidentification on an ID picture.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20050101

• A cost-effectiveness model of escitalopram, citalopram,and venlafaxine as first-line treatment for major depressive disorder in Belgium.

  Clinical therapeutics 20050101

• Antidepressant and memory affecting influence of estrogen and venlafaxine in ovariectomized rats.

  Arzneimittel-Forschung 20050101

• Effects of venlafaxine treatment on clozapine plasma levels in schizophrenic patients.

  Neuropsychobiology 20050101

• [Effects of venlafaxine extended release formulation on the clinical management of patients].

  Actas espanolas de psiquiatria 20050101

• [The current challenges of the treatment of depression: venlafaxina extended release and remission outcomes in real-world clinical practice].

  Actas espanolas de psiquiatria 20050101

• Remission from depression : a review of venlafaxine clinical and economic evidence.

  PharmacoEconomics 20050101

• Multimodal therapy of treatment resistant depression: a study and analysis.

  International journal of psychiatry in medicine 20050101

• Medroxyprogesterone acetate better than venlafaxine at relieving hot flashes.

  The journal of supportive oncology 20050101

• Venlafaxine extended release versus conventional antidepressants in the remission of depressive disorders after previous antidepressant failure: ARGOS study.

  Depression and anxiety 20050101

• Venlafaxine in the treatment of depressive and vasomotor symptoms in women with perimenopausal depression.

  Depression and anxiety 20050101

• [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].

  L'Encephale 20050101

• Reversible hyponatremia and venlafaxine.

  Psychosomatics 20050101

• The role of venlafaxine and duloxetine in the treatment of depression with decremental changes in somatic symptoms of pain, chronic pain, and the pharmacokinetics and clinical considerations of duloxetine pharmacotherapy.

  American journal of therapeutics 20050101

• Venlafaxine-induced urinary incontinence resolved after switching to sertraline.

  Clinical neuropharmacology 20050101

• Venlafaxine and asthma.

  Nordic journal of psychiatry 20050101

• Venlafaxine and bladder function.

  Clinical neuropharmacology 20050101

• [Depression and pain: novel clinical, neurobiological and psychopharmacological data].

  Psychiatria polska 20050101

• Venlafaxine and serious withdrawal symptoms: warning to drivers.

  MedGenMed : Medscape general medicine 20050101

• [Effectiveness and security of venlafaxine XR in the treatment of major depression].

  Revista medica del Instituto Mexicano del Seguro Social 20050101

• Immediate switching of antidepressant therapy: results from a clinical trial of duloxetine.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20050101

• Development of early malignant bilateral breast disease in relation to antidepressant treatment.

  Acta chirurgica Belgica 20050101

• Buspirone to improve compliance in venlafaxine-induced movement disorder.

  The international journal of neuropsychopharmacology 20041201

• Newer antidepressants in pregnancy: prospective outcome of a case series.

  Reproductive toxicology (Elmsford, N.Y.) 20041201

• Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double-blind, randomised 6-month comparative trial with citalopram.

  International journal of geriatric psychiatry 20041201

• An open treatment trial of venlafaxine for elderly patients with dysthymic disorder.

  Journal of geriatric psychiatry and neurology 20041201

• Venlafaxine for the treatment of depressive episode during the course of schizophrenia.

  Journal of clinical psychopharmacology 20041201

• S-adenosyl-L-methionine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxine.

  Journal of clinical psychopharmacology 20041201

• Effects of venlafaxine on ethanol withdrawal syndrome in rats.

  Fundamental & clinical pharmacology 20041201

• Reversible focal myositis in a patient taking venlafaxine.

  Rheumatology (Oxford, England) 20041201

• Venlafaxine versus amitriptyline in the prophylactic treatment of migraine: randomized, double-blind, crossover study.

  Clinical neurology and neurosurgery 20041201

• Narcolepsy with cataplexy.

  The American journal of psychiatry 20041201

• Combination therapy with venlafaxine and carbamazepine in depressive patients not responding to venlafaxine: pharmacokinetic and clinical aspects.

  Journal of psychopharmacology (Oxford, England) 20041201

• The response of synaptophysin and microtubule-associated protein 1 to restraint stress in rat hippocampus and its modulation by venlafaxine.

  Journal of neurochemistry 20041201

• Quantification of venlafaxine and O-desmethylvenlafaxine in human serum using HPLC analysis.

  International journal of clinical pharmacology and therapeutics 20041201

• Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors.

  The Journal of clinical psychiatry 20041201

• [Efficiency and safety of citalopram and venlafaxine in treatment of depressive disorders in elderly patients].

  Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20041201

• [Review of antidepressants from the TCAs to the third generation drugs].

  Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20041201

• Effects of venlafaxine on p90Rsk activity in rat C6-gliomas and brain.

  Neuroscience letters 20041130

• Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats.

  The Journal of pharmacology and experimental therapeutics 20041101

• Remission rates with venlafaxine extended release in Greek outpatients with generalized anxiety disorder. A double-blind, randomized, placebo controlled study.

  International clinical psychopharmacology 20041101

• Serotonin syndrome due to association of venlafaxine, maprotiline and reboxetine.

  European psychiatry : the journal of the Association of European Psychiatrists 20041101

• Clarification to SSRI table.

  Advance for nurse practitioners 20041101

• The effect of venlafaxine on behaviour, body weight and striatal monoamine levels on sleep-deprived female rats.

  Pharmacology, biochemistry, and behavior 20041101

• Antidepressant treatment-associated behavioural expression of hypomania: a case series.

  Progress in neuro-psychopharmacology & biological psychiatry 20041101

• Spontaneous orgasm started with venlafaxine and continued with citalopram.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20041101

• Venlafaxine-induced mania.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20041101

• Comment on: Serotonin syndrome due to co-administration of linezolid and venlafaxine.

  The Journal of antimicrobial chemotherapy 20041001

• Pharmacotherapy for cataplexy.

  Sleep medicine reviews 20041001

• A double-blind, placebo-controlled study of a flexible dose of venlafaxine ER in adult outpatients with generalized social anxiety disorder.

  Journal of clinical psychopharmacology 20041001

• Cost and effectiveness of venlafaxine extended-release and selective serotonin reuptake inhibitors in the acute phase of outpatient treatment for major depressive disorder.

  Journal of clinical psychopharmacology 20041001

• Efficacy and tolerability of premenstrual use of venlafaxine (flexible dose) in the treatment of premenstrual dysphoric disorder.

  Journal of clinical psychopharmacology 20041001

• Clinical experience with dual action antidepressants in different chronic pain syndromes.

  Human psychopharmacology 20041001

• Lamotrigine therapy in treatment-resistant menstrually-related rapid cycling bipolar disorder: a case report.

  Bipolar disorders 20041001

• An open trial of venlafaxine for the treatment of late-life atypical depression.

  International journal of geriatric psychiatry 20041001

• A possible case of venlafaxine-induced Stevens-Johnson syndrome.

  The Journal of clinical psychiatry 20041001

• Efficacy of open-label venlafaxine in subjects with major depressive disorder: associations with neuroendocrine response to serotonergic and noradrenergic probes.

  Psychiatry research 20040930

• Opioid and monoamine systems mediate the discriminative stimulus of tramadol in rats.

  European journal of pharmacology 20040913

• The role of alpha1- and alpha2-adrenoreceptors on venlafaxine-induced elevation of extracellular serotonin, noradrenaline and dopamine levels in the rat prefrontal cortex and hippocampus.

  Journal of psychopharmacology (Oxford, England) 20040901

• Antidepressant-like effect of tramadol and its enantiomers in reserpinized mice: comparative study with desipramine, fluvoxamine, venlafaxine and opiates.

  Journal of psychopharmacology (Oxford, England) 20040901

• A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder.

  The Journal of clinical psychiatry 20040901

• [Lethal diabetic ketoacidosis in a schizophrenic patient].

  Ugeskrift for laeger 20040823

• Social adjustment in generalised anxiety disorder: a long-term placebo-controlled study of venlafaxine extended release.

  European psychiatry : the journal of the Association of European Psychiatrists 20040801

• Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study.

  Pain 20040801

• Cost-effectiveness of psychological and pharmacological interventions for generalized anxiety disorder and panic disorder.

  The Australian and New Zealand journal of psychiatry 20040801

• Efficacy of Venlafaxine ER in patients with social anxiety disorder: a double-blind, placebo-controlled, parallel-group comparison with paroxetine.

  Human psychopharmacology 20040801

• Very low dose quetiapine-induced galactorrhea in combination with venlafaxine.

  Human psychopharmacology 20040801

• Withdrawal reactions associated with low-dose venlafaxine treatment in a patient with premenstrual dysphoric disorder.

  The Journal of clinical psychiatry 20040801

• Elevated defibrillation threshold with venlafaxine therapy.

  Pharmacotherapy 20040801

• Selective serotonin reuptake inhibitor and venlafaxine use in children and adolescents with major depressive disorder: a systematic review of published randomized controlled trials.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20040801

• Complete relief of pain in acute painful diabetic neuropathy of rapid glycaemic control (insulin neuritis) with venlafaxine HCL.

  Diabetes, nutrition & metabolism 20040801

• The novel monoamine reuptake inhibitor and potential antidepressant, S33005, induces Arc gene expression in cerebral cortex.

  European journal of pharmacology 20040714

• Mechanisms for the inhibition of genital vascular responses by antidepressants in a female rabbit model.

  The Journal of pharmacology and experimental therapeutics 20040701

• Serotonin syndrome due to co-administration of linezolid and venlafaxine.

  The Journal of antimicrobial chemotherapy 20040701

• Management of hot flashes in breast cancer survivors and men with prostate cancer.

  Current oncology reports 20040701

• Reboxetine adjunct for partial or nonresponders to antidepressant treatment.

  Journal of affective disorders 20040701

• Venlafaxine-associated hypomania in unipolar depression.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20040701

• Atypical neuroleptic malignant syndrome caused by clozapine and venlafaxine: early brief treatment with dantrolene.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20040701

• Predictors of improved mood over time in clinical trials for major depression.

  Psychiatry research 20040630

• Simple and an efficient method for the synthesis of 1-[2-dimethylamino-1-(4-methoxy-phenyl)-ethyl]-cyclohexanol hydrochloride: (+/-) venlafaxine racemic mixtures.

  Bioorganic & medicinal chemistry letters 20040621

• Non-selective opioid receptor antagonism of the antidepressant-like effect of venlafaxine in the forced swimming test in mice.

  Neuroscience letters 20040603

• Venlafaxine and sour date nut.

  The American journal of psychiatry 20040601

• A case of social phobia and avoidant personality disorder with erectile dysfunction successfully treated with venlafaxine and add-on reboxetine.

  European psychiatry : the journal of the Association of European Psychiatrists 20040601

• Tolerability of high-dose venlafaxine in depressed patients.

  Journal of psychopharmacology (Oxford, England) 20040601

• A double-blind, randomized, 26-week study comparing the cognitive and psychomotor effects and efficacy of 75 mg (37.5 mg b.i.d.) venlafaxine and 75 mg (25 mg mane, 50 mg nocte) dothiepin in elderly patients with moderate major depression being treated in general practice.

  Journal of psychopharmacology (Oxford, England) 20040601

• Impact of gastrointestinal symptom severity on response to venlafaxine extended-release in patients with generalized anxiety disorder.

  The Journal of clinical psychiatry 20040601

• Venlafaxine-induced increase in urinary frequency in 3 women.

  The Journal of clinical psychiatry 20040601

• Venlafaxine XR and chronic pelvic pain syndrome.

  The Journal of clinical psychiatry 20040601

• Depression in children and adolescents.

  Clinical evidence 20040601

• Blockade of supraspinal 5-HT1A receptors potentiates the inhibitory effect of venlafaxine on wind-up activity in mononeuropathic rats.

  Brain research 20040522

• Effect of gabapentin derivates on mechanical allodynia-like behaviour in a rat model of chronic sciatic constriction injury.

  Bioorganic & medicinal chemistry letters 20040517

• Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose?

  European journal of clinical pharmacology 20040501

• Management of anorexia nervosa revisited: drug treatment suggestions are questionable.

  BMJ (Clinical research ed.) 20040501

• Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.

  The American journal of psychiatry 20040501

• Venlafaxine and SSRI remission data revisited.

  The British journal of psychiatry : the journal of mental science 20040501

• Alleviation of erythromelalgia with venlafaxine.

  Archives of dermatology 20040501

• Treatment of pain syndromes with venlafaxine.

  Pharmacotherapy 20040501

• Venlafaxine in the treatment of anxiety disorders.

  Expert review of neurotherapeutics 20040501

• [Vital functions at risk. Dealing with depressions rapidly and comprehensively].

  MMW Fortschritte der Medizin 20040426

• The novel monoamine reuptake inhibitor and potential antidepressant, S33005, induces Arc gene expression in cerebral cortex.

  European journal of pharmacology 20040412

• Value in venlafaxine study.

  The British journal of general practice : the journal of the Royal College of General Practitioners 20040401

• The effects of the DRD2 polymorphism on smoking cessation and negative affect: evidence for a pharmacogenetic effect on mood.

  Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20040401

• Venlafaxine withdrawal syndrome: report of seven cases in Trinidad.

  Journal of clinical psychopharmacology 20040401

• Venlafaxine induced hepatitis.

  The Journal of the Association of Physicians of India 20040401

• Update: A 75-year-old man with depression.

  JAMA 20040310

• Comparisons of psychotropic drug prescribing patterns in acute psychiatric wards across Europe.

  European journal of clinical pharmacology 20040301

• Serotonin syndrome resulting from coadministration of tramadol, venlafaxine, and mirtazapine.

  The Annals of pharmacotherapy 20040301

• Venlafaxine versus placebo in the preventive treatment of recurrent major depression.

  The Journal of clinical psychiatry 20040301

• Is Effexor more effective for depression than an SSRI?

  The Medical letter on drugs and therapeutics 20040216

• Venlafaxine in children and adolescents with attention deficit hyperactivity disorder.

  Psychiatry and clinical neurosciences 20040201

• Venlafaxine-induced depression of wind-up activity in mononeuropathic rats is potentiated by inhibition of brain 5-HT1A receptor expression in vivo.

  The International journal of neuroscience 20040201

• Time course of clinical response to venlafaxine: relevance of plasma level and chirality.

  European journal of clinical pharmacology 20040201

• Comparative CYP3A4 inhibitory effects of venlafaxine, fluoxetine, sertraline, and nefazodone in healthy volunteers.

  Journal of clinical psychopharmacology 20040201

• Low-dose venlafaxine-associated liver toxicity in chronic hepatitis.

  The Annals of pharmacotherapy 20040201

• Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity.

  Biological psychiatry 20040201

• Comparison study of venlafaxine and paroxetine for the treatment of depression in elderly Chinese inpatients.

  International journal of geriatric psychiatry 20040201

• Making sense of the evidence regarding nonhormonal treatments for hot flashes.

  Clinical journal of oncology nursing 20040201

• Stimulatory effect of antidepressants on the production of IL-6.

  International immunopharmacology 20040201

• Any value in venlafaxine study?

  The British journal of general practice : the journal of the Royal College of General Practitioners 20040201

• Evaluation of efficacy of the perioperative administration of venlafaxine XR in the prevention of postmastectomy pain syndrome.

  Journal of pain and symptom management 20040201

• Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society.

  Menopause (New York, N.Y.) 20040101

• The treatment of depression with different formulations of venlafaxine: a comparative analysis.

  Human psychopharmacology 20040101

• Acute and continuation treatment adequacy with venlafaxine extended release compared with fluoxetine.

  Pharmacotherapy 20040101

• A double-blind switch study of paroxetine and venlafaxine in obsessive-compulsive disorder.

  The Journal of clinical psychiatry 20040101

• Combined oral venlafaxine and intravenous clomipramine-A: successful temporary response in a patient with extremely refractory depression.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20040101

• [An improved novel method of venlafaxine synthesis].

  Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20040101

• Mirtazapine is associated with less anxiolytic use among elderly depressed patients in long-term care facilities.

  Journal of the American Medical Directors Association 20040101

• Response to 'Wishful pharmaceutical thinking'.

  The British journal of general practice : the journal of the Royal College of General Practitioners 20040101

• Extended-release venlafaxine in relapse prevention for patients with major depressive disorder.

  Journal of psychiatric research 20040101

• Pooled analysis of venlafaxine XR efficacy on somatic and psychic symptoms of anxiety in patients with generalized anxiety disorder.

  Depression and anxiety 20040101

• [Venlafaxine extended release for the treatment of chronic pain. A series of 50 cases].

  Actas espanolas de psiquiatria 20040101

• Selective versus multi-transmitter antidepressants: are two mechanisms better than one?

  The Journal of clinical psychiatry 20040101

• Depression in primary care: effectiveness of venlafaxine extended-release in elderly patients; Observational study.

  Archives of gerontology and geriatrics 20040101

• Comparative toxicity of citalopram and the newer antidepressants after overdose.

  Journal of toxicology. Clinical toxicology 20040101

• Worsening of psychosis or topiramate-induced adverse event?

  General hospital psychiatry 20040101

• Safety and tolerability of extended-release venlafaxine in severe medical and surgical illness.

  Psychosomatics 20040101

• A randomised study comparing escitalopram with venlafaxine XR in primary care patients with major depressive disorder.

  Neuropsychobiology 20040101

• New formulations of existing antidepressants: advantages in the management of depression.

  CNS drugs 20040101

• Off-label prescribing of drugs in specialty headache practice.

  Headache 20040101

• Venlafaxine in the treatment of atypical facial pain: a randomized controlled trial.

  Journal of orofacial pain 20040101

• Recovery of hippocampal cell proliferation and BDNF levels, both of which are reduced by repeated restraint stress, is accelerated by chronic venlafaxine.

  The pharmacogenomics journal 20040101

• Common pathways of depression and pain.

  The Journal of clinical psychiatry 20040101

• Therapeutic drug monitoring of non-tricyclic antidepressant drugs.

  Clinical chemistry and laboratory medicine 20040101

• SNRIs in the management of acute major depressive disorder.

  The Journal of clinical psychiatry 20040101

• Qualitative review of SNRIs in anxiety.

  The Journal of clinical psychiatry 20040101

• Long-term management of major depressive disorder: are differences among antidepressant treatments meaningful?

  The Journal of clinical psychiatry 20040101

• Kleptomania after head trauma: two case reports and combination treatment strategies.

  Clinical neuropharmacology 20040101

• A hot flash on tamoxifen metabolism.

  Journal of the National Cancer Institute 20031203

• Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats.

  Neuropharmacology 20031201

• A double blind comparison of venlafaxine and paroxetine in obsessive-compulsive disorder.

  Journal of clinical psychopharmacology 20031201

• Antidepressant monotherapy for bipolar type II major depression.

  Bipolar disorders 20031201

• Lithium encephalopathy.

  Journal of the Royal Society of Medicine 20031201

• Hypertensive crisis associated with venlafaxine.

  The American journal of medicine 20031201

• ECT resistance and early relapse: two cases of subsequent response to venlafaxine.

  The journal of ECT 20031201

• Should children take antidepressants?

  The Harvard mental health letter 20031201

• Fatality related to a 30-g venlafaxine overdose.

  Pharmacotherapy 20031201

• Venlafaxine withdrawal in organic anxiety disorder.

  Indian journal of medical sciences 20031201

• Fluoxetine dose-increment related akathisia in depression: implications for clinical care, recognition and management of selective serotonin reuptake inhibitor-induced akathisia.

  Journal of psychopharmacology (Oxford, England) 20031201

• Treatment considerations for anxiety in the elderly.

  CNS spectrums 20031201

• Wishful pharmaceutical thinking.

  The British journal of general practice : the journal of the Royal College of General Practitioners 20031201

• Hormone therapy after endometrial cancer.

  The journal of the British Menopause Society 20031201

• Effects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow: a microdialysis study in Swiss mice.

  British journal of pharmacology 20031101

• Venlafaxine treatment of fibromyalgia.

  The Annals of pharmacotherapy 20031101

• Venlafaxine hydrochloride for the treatment of hot flashes.

  The Annals of pharmacotherapy 20031101

• A score for predicting response to pharmacotherapy in obsessive-compulsive disorder.

  International clinical psychopharmacology 20031101

• Report of a case of immunosuppression with prednisone in an 8-year-old boy with an acute onset of hypocretin-deficiency narcolepsy.

  Sleep 20031101

• Mirtazapine-induced hyponatraemia.

  The Medical journal of Australia 20031020

• Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-glycoprotein gene disruption.

  Biological psychiatry 20031015

• [Pharmacotherapy of generalized anxiety disorder: state of the art].

  Praxis 20031015

• A double-blind, randomised, placebo controlled study of venlafaxine XL in patients with generalised anxiety disorder in primary care.

  The British journal of general practice : the journal of the Royal College of General Practitioners 20031001

• Lithium augmentation in venlafaxine non-responders: an open study.

  European psychiatry : the journal of the Association of European Psychiatrists 20031001

• Effects of venlafaxine on extracellular 5-HT, dopamine and noradrenaline in the hippocampus and on peripheral hormone concentrations in the rat in vivo.

  Life sciences 20030926

• [Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy].

  Nederlands tijdschrift voor geneeskunde 20030920

• Effect of ketoconazole on venlafaxine plasma concentrations in extensive and poor metabolisers of debrisoquine.

  European journal of clinical pharmacology 20030901

• The safety of SSRIs in generalised anxiety disorder: any reason to be anxious?

  Expert opinion on drug safety 20030901

• The use of antidepressants to treat attention deficit hyperactivity disorder in adults.

  Journal of psychopharmacology (Oxford, England) 20030901

• Treatment of toxic epidermal necrolysis with intravenous immunoglobulin.

  International journal of clinical practice 20030901

• Efficacy and safety of venlafaxine ER vs. amitriptyline ER in patients with major depression of moderate severity.

  Pharmacopsychiatry 20030901

• Dosage finding and outcome of venlafaxine treatment in psychiatric outpatients and inpatients: results of a drug utilization observation study.

  Pharmacopsychiatry 20030901

• [Antidepressive treatment and subcapsular splenic hematoma].

  Anales de medicina interna (Madrid, Spain : 1984) 20030901

• Risperidone-responsive segmental dystonia and pallidal deep brain stimulation.

  Neurology 20030826

• Evidence for an antihyperalgesic effect of venlafaxine in vincristine-induced neuropathy in rat.

  Brain research 20030801

• Infinite enantiomeric resolution of basic compounds using highly sulfated cyclodextrin as chiral selector in capillary electrophoresis.

  Electrophoresis 20030801

• Selective serotonin reuptake inhibitors combined with venlafaxine in depressed patients who had partial response to venlafaxine: four cases.

  Progress in neuro-psychopharmacology & biological psychiatry 20030801

• Probing the safety of medications in the frail elderly: evidence from a randomized clinical trial of sertraline and venlafaxine in depressed nursing home residents.

  The Journal of clinical psychiatry 20030801

• Venlafaxine: a 2003 update.

  Clinical therapeutics 20030801

• [Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy].

  Nederlands tijdschrift voor geneeskunde 20030712

• Investigation of epistasis between the serotonin transporter and norepinephrine transporter genes in anorexia nervosa.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030701

• A case report of paranoid delusion with venlafaxine use.

  Journal of the American Geriatrics Society 20030701

• Protection against oxaliplatin acute neurosensory toxicity by venlafaxine.

  Anti-cancer drugs 20030701

• Suggested guidelines for e-mail communication in psychiatric practice.

  The Journal of clinical psychiatry 20030701

• Diabetic ketoacidosis in a patient treated with olanzapine, valproic acid, and venlafaxine.

  Southern medical journal 20030701

• Effective open-label treatment of premenstrual dysphoric disorder with venlafaxine.

  Psychiatry and clinical neurosciences 20030601

• Effects of 5-HT(6) receptor blockade on the neurochemical outcome of antidepressant treatment in the frontal cortex of the rat.

  Journal of neural transmission (Vienna, Austria : 1996) 20030601

• Randomized controlled trials in psychiatry. Part 1: methodology and critical evaluation.

  The Australian and New Zealand journal of psychiatry 20030601

• Evidence for a monoamine mediated, opioid-independent, antihyperalgesic effect of venlafaxine, a non-tricyclic antidepressant, in a neurogenic pain model in rats.

  Pain 20030601

• A method for controlling for a high placebo response rate in a comparison of venlafaxine XR and diazepam in the short-term treatment of patients with generalised anxiety disorder.

  European psychiatry : the journal of the Association of European Psychiatrists 20030601

• Statistical considerations about the question of a selection of discriminating centres in the analysis of clinical trial. In response to the paper: 'A method for controlling for a high response rate in a comparison of venlafaxine XR and diazepan in the short-term treatment of patients with generalised anxiety disorder'.

  European psychiatry : the journal of the Association of European Psychiatrists 20030601

• Venlafaxine for pathological crying after stroke.

  The Journal of clinical psychiatry 20030601

• Predictors of outcome following venlafaxine extended-release treatment of DSM-IV generalized anxiety disorder: a pooled analysis of short- and long-term studies.

  Journal of clinical psychopharmacology 20030601

• The antinociceptive effect of tramadol-venlafaxine combination on the paw withdrawal threshold in a rat model of neuropathic pain.

  Methods and findings in experimental and clinical pharmacology 20030601

• Venlafaxine treatment of obsessive-compulsive disorder: case reports.

  CNS spectrums 20030601

• [Reversible and dose-related parkinsonism induced by venlafaxine].

  Medicina clinica 20030524

• The antihyperalgesic effect of venlafaxine in diabetic rats does not involve the opioid system.

  Neuroscience letters 20030515

• Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants.

  QJM : monthly journal of the Association of Physicians 20030501

• Hepatic injury and pancreatitis during treatment with serotonin reuptake inhibitors: data from the World Health Organization (WHO) database of adverse drug reactions.

  International clinical psychopharmacology 20030501

• Gabapentin and posttraumatic stress disorder.

  The Annals of pharmacotherapy 20030501

• Serotonin syndrome after single doses of co-amoxiclav during treatment with venlafaxine.

  Journal of the Royal Society of Medicine 20030501

• Shock-like sensations during venlafaxine withdrawal.

  Pharmacotherapy 20030501

• The effects of venlafaxine on the subjective, reinforcing, and cardiovascular effects of cocaine in opioid-dependent and non-opioid-dependent humans.

  Experimental and clinical psychopharmacology 20030501

• Venlafaxine in treatment-resistant obsessive-compulsive disorder.

  The Journal of clinical psychiatry 20030501

• SSRIs in IBS: sensing a dash of disappointment.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20030501

• Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20030501

• Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial.

  Neurology 20030422

• Venlafaxine and increased aggression in a female with autism.

  Journal of the American Academy of Child and Adolescent Psychiatry 20030401

• Dual action antidepressants and some important considerations.

  The Australian and New Zealand journal of psychiatry 20030401

• Erotomania induced by venlafaxine: a case study.

  Acta psychiatrica Scandinavica 20030401

• Drug-induced pneumonitis and heart failure simultaneously associated with venlafaxine.

  American journal of respiratory and critical care medicine 20030401

• Venlafaxine: not yet first in the antidepressant class.

  The Harvard mental health letter 20030401

• Venlafaxine-induced delirium.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20030301

• Emerging skin-picking behaviour after serotonin reuptake inhibitor-treatment in patients with obsessive-compulsive disorder: possible mechanisms and implications for clinical care.

  Journal of psychopharmacology (Oxford, England) 20030301

• Depression-free days as a summary measure of the temporal pattern of response and remission in the treatment of major depression: a comparison of venlafaxine, selective serotonin reuptake inhibitors, and placebo.

  The Journal of clinical psychiatry 20030301

• Mania associated with venlafaxine discontinuation.

  The international journal of neuropsychopharmacology 20030301

• A case of venlafaxine abuse.

  The New England journal of medicine 20030220

• Single-blind comparison of venlafaxine and nortriptyline in elderly major depression.

  Journal of clinical psychopharmacology 20030201

• The effect of one-week treatment with venlafaxine on 35% CO2 hyperreactivity in patients with panic disorder: an open study.

  Journal of clinical psychopharmacology 20030201

• Venlafaxine-induced galactorrhea.

  Journal of clinical psychopharmacology 20030201

• Serotonin syndrome induced by low-dose venlafaxine.

  The Annals of pharmacotherapy 20030201

• Changes in regional cerebral blood flow with venlafaxine in the treatment of major depression.

  The American journal of psychiatry 20030201

• Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients.

  The American journal of medicine 20030201

• Depression in children and adolescents.

  American family physician 20030201

• Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health.

  American journal of physiology. Gastrointestinal and liver physiology 20030101

• Effect of a pharmacological intervention on quality of life in patients with obsessive-compulsive disorder.

  International clinical psychopharmacology 20030101

• Dose-related effects of chronic antidepressants on neuroprotective proteins BDNF, Bcl-2 and Cu/Zn-SOD in rat hippocampus.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030101

• The neural substrates of affective processing in depressed patients treated with venlafaxine.

  The American journal of psychiatry 20030101

• Fentanyl-induced rigidity during emergence from general anesthesia potentiated by venlafexine.

  Canadian journal of anaesthesia = Journal canadien d'anesthesie 20030101

• Role of CYP2D6 in the stereoselective disposition of venlafaxine in humans.

  Pharmacogenetics 20030101

• Diffusion of new generation antidepressant treatment among elderly diagnosed with depression.

  Medical care 20030101

• [Venlafaxine titration dosage in depressive in-patients. A series of cases].

  Actas espanolas de psiquiatria 20030101

• New hope in the treatment of painful symptoms in depression.

  Current opinion in investigational drugs (London, England : 2000) 20030101

• Treating generalized anxiety disorder.

  The Journal of clinical psychiatry 20030101

• A pharmacoeconomic evaluation of major depressive disorder.

  Managed care interface 20030101

• Melperone is an inhibitor of the CYP2D6 catalyzed O-demethylation of venlafaxine.

  Pharmacopsychiatry 20030101

• Seizures associated with venlafaxine, methylphenidate, and zolpidem.

  Psychosomatics 20030101

• Physical symptoms of depression: unmet needs in special populations.

  The Journal of clinical psychiatry 20030101

• Comparison of behavioural effects of venlafaxine and imipramine in rats.

  Arzneimittel-Forschung 20030101

• Severe headache with venlafaxine withdrawal.

  The Annals of pharmacotherapy 20030101

• Reassessment of global benefit-risk assessment of antidepressants: venlafaxine XR and fluoxetine.

  Journal of psychiatric research 20030101

• Efficacy of venlafaxine for the long term treatment of chronic pain with associated major depressive disorder.

  American journal of therapeutics 20030101

• Using absolute and relative reasoning in the prediction of the potential metabolism of xenobiotics.

  Journal of chemical information and computer sciences 20030101

• Antidepressant drug treatment induces Arc gene expression in the rat brain.

  Neuroscience 20030101

• [Quality of life, in depressed patients in Primary Health Care setting. Effectiveness and safety of venlafaxine extended release].

  Actas espanolas de psiquiatria 20030101

• Immediate-release versus controlled-release formulations: pharmacokinetics of newer antidepressants in relation to nausea.

  The Journal of clinical psychiatry 20030101

• Improving antidepressant adherence.

  The Journal of clinical psychiatry 20030101

• Massive venlafaxine overdose resulted in a false positive Abbott AxSYM urine immunoassay for phencyclidine.

  Journal of toxicology. Clinical toxicology 20030101

• Psychopharmacology news.

  Journal of child and adolescent psychopharmacology 20030101

• Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression.

  Biological psychiatry 20021215

• Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of United Kingdom mortality data.

  BMJ (Clinical research ed.) 20021207

• Fanconi and inappropriate secretion of antidiuretic hormone syndromes secondary to venlafaxine therapy.

  Nephron 20021201

• Venlafaxine open-label treatment of patients with obsessive-compulsive disorder.

  The Australian and New Zealand journal of psychiatry 20021201

• Effectiveness of venlafaxine, extended release formulation, in the short-term and long-term treatment of generalized anxiety disorder: results of a survival analysis.

  Journal of clinical psychopharmacology 20021201

• A case of venlafaxine-induced inhibition of T-lymphocyte proliferation.

  Psychopharmacology 20021201

• Venlafaxine and reversible blepharoedema.

  The international journal of neuropsychopharmacology 20021201

• Alternative venlafaxine kinetics in overdose.

  Journal of clinical pharmacy and therapeutics 20021201

• Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study.

  Journal of psychopharmacology (Oxford, England) 20021201

• Venlafaxine: the relationship between dose, plasma concentration and clinical response in depressive patients.

  Journal of psychopharmacology (Oxford, England) 20021201

• Human variability in polymorphic CYP2D6 metabolism: is the kinetic default uncertainty factor adequate?

  Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20021101

• Two items on the Hamilton Depression rating scale are effective predictors of remission: comparison of selective serotonin reuptake inhibitors with the combined serotonin/norepinephrine reuptake inhibitor, venlafaxine.

  International clinical psychopharmacology 20021101

• Venlafaxine versus clomipramine in the treatment of obsessive-compulsive disorder: a preliminary single-blind, 12-week, controlled study.

  The Journal of clinical psychiatry 20021101

• The brain tells: early signs of depression recovery.

  The Harvard mental health letter 20021101

• Hypokalemia with venlafaxine.

  The Journal of clinical psychiatry 20021101

• Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine.

  Pharmacopsychiatry 20021101

• Serotonin syndrome induced by amitriptyline, meperidine, and venlafaxine.

  The Annals of pharmacotherapy 20021001

• Interaction between ECT and venlafaxine.

  International journal of geriatric psychiatry 20021001

• Safety and efficacy of high dose of venlafaxine XL in treatment resistant major depression.

  Human psychopharmacology 20021001

• Treatment of posttraumatic stress disorder with tiagabine.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20021001

• Efficacy of venlafaxine in major depression resistant to selective serotonin reuptake inhibitors.

  Progress in neuro-psychopharmacology & biological psychiatry 20021001

• Treatment for hot flushes in women receiving tamoxifen.

  The Medical journal of Australia 20020902

• Venlafaxine: a new class of antidepressant.

  Hospital medicine (London, England : 1998) 20020901

• Venlafaxine treatment of binge-eating disorder associated with obesity: a series of 35 patients.

  The Journal of clinical psychiatry 20020901

• Venlafaxine in a patient with idiopathic leukopenia and mirtazapine-induced severe neutropenia.

  The Journal of clinical psychiatry 20020901

• [Pharmacological justification for the use of new antidepressant drugs].

  Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20020901

• Long-term side effects of newer-generation antidepressants: SSRIS, venlafaxine, nefazodone, bupropion, and mirtazapine.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20020901

• Venlafaxine in the treatment of painful peripheral diabetic neuropathy in a uremic patient undergoing hemodialysis.

  MedGenMed : Medscape general medicine 20020821

• Comparison of the effects of serotonin selective, norepinephrine selective, and dual serotonin and norepinephrine reuptake inhibitors on lower urinary tract function in cats.

  Life sciences 20020802

• Effects on drug disposition, brain monoamines and behavior after chronic treatment with the antidepressant venlafaxine in rats with experimental hepatic encephalopathy.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20020801

• Therapeutic drug monitoring of racemic venlafaxine and its main metabolites in an everyday clinical setting.

  Therapeutic drug monitoring 20020801

• Steady-state concentration of venlafaxine enantiomers: model-based analysis of between-patient variability.

  European journal of clinical pharmacology 20020801

• Dramatic recovery of paclitaxel-disabling neurosensory toxicity following treatment with venlafaxine.

  Anti-cancer drugs 20020801

• Combining antidepressants for treatment-resistant depression: a review.

  The Journal of clinical psychiatry 20020801

• Quetiapine addition to serotonin reuptake inhibitor treatment in patients with treatment-refractory obsessive-compulsive disorder: an open-label study.

  The Journal of clinical psychiatry 20020801

• Treating hot flashes with drugs: an update.

  Harvard women's health watch 20020801

• Venlafaxine poisoning complicated by a late rise in creatine kinase: two case reports.

  Human & experimental toxicology 20020801

• Early changes in prefrontal activity characterize clinical responders to antidepressants.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20020701

• Once daily sustained release tablets of venlafaxine, a novel antidepressant.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20020701

• Social adjustment in depressed patients treated with venlafaxine and amitriptyline.

  International clinical psychopharmacology 20020701

• Efficacy of venlafaxine in patients with major depressive disorder who have unsustained or no response to selective serotonin reuptake inhibitors: an open-label, uncontrolled study.

  Clinical therapeutics 20020701

• Serotonin syndrome produced by a combination of venlafaxine and mirtazapine.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20020701

• [Delirium during withdrawal of venlafaxine].

  Nederlands tijdschrift voor geneeskunde 20020629

• Stability indicating LC method for the estimation of venlafaxine in pharmaceutical formulations.

  Journal of pharmaceutical and biomedical analysis 20020615

• PHARMAC and availability of pharmaceuticals.

  The New Zealand medical journal 20020607

• Gabapentin in complicated school refusal.

  Journal of the American Academy of Child and Adolescent Psychiatry 20020601

• Treatment costs of venlafaxine and selective serotonin-reuptake inhibitors for depression and anxiety.

  Managed care interface 20020601

• A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers.

  The Journal of clinical psychiatry 20020601

• Rapid onset of antidepressant activity with venlafaxine.

  The Journal of clinical psychiatry 20020601

• Inhibition by venlafaxine of the increase in norepinephrine output in rat prefrontal cortex elicited by acute stress or by the anxiogenic drug FG 7142.

  Journal of psychopharmacology (Oxford, England) 20020601

• Venlafaxine compared with fluoxetine in outpatients with depression and concomitant anxiety.

  The international journal of neuropsychopharmacology 20020601

• An overview of the clinical efficacy of mirtazapine.

  Human psychopharmacology 20020601

• Disposition of venlafaxine enantiomers in rats with hepatic encephalopathy after chronic drug treatment.

  Chirality 20020505

• Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis.

  The British journal of psychiatry : the journal of mental science 20020501

• Venlafaxine-associated vaginal bleeding.

  Pharmacotherapy 20020501

• Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents.

  Pharmacology, biochemistry, and behavior 20020401

• Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive rats.

  Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20020401

• Venlafaxine versus stimulant therapy in patients with dual diagnosis ADD and depression.

  Progress in neuro-psychopharmacology & biological psychiatry 20020401

• Prevalence of sexual dysfunction among newer antidepressants.

  The Journal of clinical psychiatry 20020401

• A 75-year-old man with depression.

  JAMA 20020327

• Serotonin toxicity with therapeutic doses of dexamphetamine and venlafaxine.

  The Medical journal of Australia 20020304

• Venlafaxine and bilateral acute angle closure glaucoma.

  The Medical journal of Australia 20020304

• Hyponatraemia in elderly psychiatric patients treated with Selective Serotonin Reuptake Inhibitors and venlafaxine: a retrospective controlled study in an inpatient unit.

  International journal of geriatric psychiatry 20020301

• Antidepressant side effects in depression patients treated in a naturalistic setting: a study of bupropion, moclobemide, paroxetine, sertraline, and venlafaxine.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20020301

• Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: a preliminary report on pharmacokinetic, therapeutic, and sexual dysfunction effects.

  The Journal of clinical psychiatry 20020301

• Reporting of randomised trials.

  The British journal of psychiatry : the journal of mental science 20020201

• Effects of chronically administered venlafaxine on 5-HT receptor activity in rat hippocampus and hypothalamus.

  European journal of pharmacology 20020201

• Treatment of erythromelalgia with a serotonin/noradrenaline reuptake inhibitor.

  The British journal of dermatology 20020201

• Can improvement in well-being and functioning be distinguished from depression improvement in antidepressant clinical trials?

  Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 20020201

• Changes in brain function of depressed subjects during treatment with placebo.

  The American journal of psychiatry 20020101

• Noradrenergic antidepressants: does chronic treatment increase or decrease nuclear CREB-P?

  Journal of neural transmission (Vienna, Austria : 1996) 20020101

• Beyond estrogen: new alternatives for the management of hot flashes.

  South Dakota journal of medicine 20020101

• Serotonin syndrome caused by selective serotonin reuptake-inhibitors-metoclopramide interaction.

  The Annals of pharmacotherapy 20020101

• Venlafaxine for the control of hot flashes: results of a longitudinal continuation study.

  Oncology nursing forum 20020101

• Distribution of venlafaxine and its O-desmethyl metabolite in human milk and their effects in breastfed infants.

  British journal of clinical pharmacology 20020101

• Global benefit-risk assessment of antidepressants: venlafaxine XR and fluoxetine.

  Journal of psychiatric research 20020101

• Venlafaxine in neuropathic pain following treatment of breast cancer.

  European journal of pain (London, England) 20020101

• False-positive phencyclidine immunoassay results caused by venlafaxine and O-desmethylvenlafaxine.

  Clinical chemistry 20020101

• Treatment of psychotic depression associated with steroid therapy in Churg-Strauss syndrome.

  Irish medical journal 20020101

• Venlafaxine and mirtazapine: different mechanisms of antidepressant action, common opioid-mediated antinociceptive effects--a possible opioid involvement in severe depression?

  Journal of molecular neuroscience : MN 20020101

• Efficacy and safety of venlafaxine-ECT combination in treatment-resistant depression.

  The Journal of neuropsychiatry and clinical neurosciences 20020101

• Venlafaxine ER as a treatment for generalized anxiety disorder in older adults: pooled analysis of five randomized placebo-controlled clinical trials.

  Journal of the American Geriatrics Society 20020101

• Treatment of generalized anxiety disorder.

  The Journal of clinical psychiatry 20020101

• Generalized anxiety disorder in primary care: emerging issues in management and treatment.

  The Journal of clinical psychiatry 20020101

• Masturbatory guilt leading to severe depression and erectile dysfunction.

  Journal of sex & marital therapy 20020101

• Healthcare expenditure in patients treated with venlafaxine or selective serotonin reuptake inhibitors for depression and anxiety.

  International journal of clinical practice 20020101

• Characterization of the longitudinal course of improvement in generalized anxiety disorder during long-term treatment with venlafaxine XR.

  Journal of psychiatric research 20020101

• Management of hot flushes in breast cancer patients.

  Acta oncologica (Stockholm, Sweden) 20020101

• Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.

  Depression and anxiety 20020101

• Lithium toxicity: a potential interaction with celecoxib.

  Internal medicine journal 20020101

• Women with PTSD: the psychodynamic aspects of psychopharmacologic and 'hands-on' psychiatric management.

  The Journal of the American Academy of Psychoanalysis 20020101

• Open-label evaluation of venlafaxine sustained release in outpatients with generalized anxiety disorder with comorbid major depression or dysthymia: effectiveness, tolerability and predictors of response.

  Neuropsychobiology 20020101

• [Acute cytolytic hepatitis after taking venlafaxine].

  Gastroenterologie clinique et biologique 20020101

• Long-term treatment strategies in anxiety disorders.

  Psychopharmacology bulletin 20020101

• Optimizing treatment outcomes for patients with depression and generalized anxiety disorder.

  Psychopharmacology bulletin 20020101

• Mechanism of action of antidepressants.

  Psychopharmacology bulletin 20020101

• Achieving remission from depression with venlafaxine and venlafaxine extended release: a literature review of comparative studies with selective serotonin reuptake inhibitors.

  Acta psychiatrica Scandinavica. Supplementum 20020101

• Pharmacotherapy of generalized anxiety disorder.

  The Journal of clinical psychiatry 20020101

• Role of neuropeptides in antidepressant and memory improving effects of venlafaxine.

  Polish journal of pharmacology 20020101

• Can monoamine-based therapies be improved?

  The Journal of clinical psychiatry 20020101

• Generalized anxiety disorder: raising the expectations of treatment.

  Psychopharmacology bulletin 20020101

• Venlafaxine- and trazodone-induced serotonin syndrome.

  The American journal of psychiatry 20011201

• Venlafaxine and breast-feeding.

  The American journal of psychiatry 20011201

• Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20011201

• Venlafaxine in the treatment of premenstrual dysphoric disorder.

  Obstetrics and gynecology 20011101

• Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo.

  The Journal of clinical psychiatry 20011101

• Pattern of symptom improvement following treatment with venlafaxine XR in patients with generalized anxiety disorder.

  The Journal of clinical psychiatry 20011101

• The effects of a selective noradrenaline reuptake inhibitor on the urethra: an in vitro and in vivo study.

  BJU international 20011101

• Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study.

  The American journal of psychiatry 20011001

• Addition of olanzapine for treatment-resistant depression.

  The American journal of psychiatry 20011001

• Pseudodementia. Cognitive decline caused by untreated depression may be reversed with treatment.

  Geriatrics 20011001

• Venlafaxine-induced hypomanic switch in bipolar depression.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20011001

• The expert consensus guideline series. Pharmacotherapy of depressive disorders in older patients.

  Postgraduate medicine 20011001

• Postmortem tissue concentrations of venlafaxine.

  Forensic science international 20010915

• Rapid high-performance liquid chromatographic measurement of venlafaxine and O-desmethylvenlafaxine in human plasma. Application to management of acute intoxications.

  Journal of chromatography. B, Biomedical sciences and applications 20010905

• The combined use of bupropion, lithium, and venlafaxine during ECT: a case of prolonged seizure activity.

  The journal of ECT 20010901

• The pharmacoeconomics of venlafaxine in depression.

  The American journal of managed care 20010901

• On-line capillary electrophoresis-electrospray mass spectrometry for the stereoselective analysis of drugs and metabolites.

  Electrophoresis 20010901

• Once-daily venlafaxine extended release (XR) vs. fluoxetine for the treatment of depression.

  Journal of affective disorders 20010901

• Microdialysis in freely moving mice: determination of acetylcholine, serotonin and noradrenaline release in galanin transgenic mice.

  Journal of neuroscience methods 20010815

• Successful use of cardiac allograft from serotonin antagonist intoxication.

  Transplantation 20010815

• S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.

  The Journal of pharmacology and experimental therapeutics 20010801

• S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.

  The Journal of pharmacology and experimental therapeutics 20010801

• Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features.

  Journal of clinical psychopharmacology 20010801

• Topiramate in venlafaxine-induced visual hallucinations in an obese patient with a posterior cerebral artery infarction.

  Journal of clinical psychopharmacology 20010801

• Flushing in a menopausal woman taking venlafaxine.

  The American journal of psychiatry 20010801

• [14C]Serotonin uptake and [O-methyl-11C]venlafaxine kinetics in porcine brain.

  Nuclear medicine and biology 20010801

• [Serotonin-noradrenaline reuptake inhibitors(SNRIs)].

  Nihon rinsho. Japanese journal of clinical medicine 20010801

• Venlafaxine in the treatment of postpartum depression.

  The Journal of clinical psychiatry 20010801

• Venlafaxine-induced hair loss.

  The American journal of psychiatry 20010701

• Venlafaxine extended release (ER) in the treatment of generalised anxiety disorder: twenty-four-week placebo-controlled dose-ranging study.

  The British journal of psychiatry : the journal of mental science 20010701

• Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: preliminary findings.

  Archives of general psychiatry 20010701

• Functional brain circuits in major depression and remission.

  Archives of general psychiatry 20010701

• Neuroimaging profiles and the differential therapies of depression.

  Archives of general psychiatry 20010701

• [Depressive disorders and antidepressive therapy. A comparison of neurology practice and psychiatric clinic].

  Der Nervenarzt 20010701

• Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder.

  The Journal of clinical psychiatry 20010701

• In vitro effects of St. John's wort extract and hyperforin on 5 HT uptake and efflux in human blood platelets.

  Pharmacopsychiatry 20010701

• Sertraline, paroxetine, and venlafaxine in refugee posttraumatic stress disorder with depression symptoms.

  Journal of traumatic stress 20010701

• Short-term administration of fluoxetine and venlafaxine decreases corticosteroid receptor mRNA expression in the rat hippocampus.

  Neuroscience letters 20010629

• Antidepressant discontinuation (withdrawal) symptoms presenting as 'stroke'.

  Journal of psychopharmacology (Oxford, England) 20010601

• The health economic impact of antidepressant usage from a payer's perspective: a multinational study.

  International journal of clinical practice 20010601

• Use of vancomycin silica stationary phase in packed capillary electrochromatography. II. Enantiomer separation of venlafaxine and O-desmethylvenlafaxine in human plasma.

  Journal of chromatography. A 20010601

• Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: a replication analysis of the Food and Drug Administration Database.

  The international journal of neuropsychopharmacology 20010601

• Attenuation of morphine dependence and withdrawal in rats by venlafaxine, a serotonin and noradrenaline reuptake inhibitor.

  Life sciences 20010525

• Recurrent depression with vagus nerve stimulation.

  The American journal of psychiatry 20010501

• Treatment of neuropathic pain with venlafaxine.

  The Annals of pharmacotherapy 20010501

• Simultaneous screen for microsomal stability and metabolite profile by direct injection turbulent-laminar flow LC-LC and automated tandem mass spectrometry.

  Analytical chemistry 20010501

• Diphenhydramine alters the disposition of venlafaxine through inhibition of CYP2D6 activity in humans.

  Journal of clinical psychopharmacology 20010401

• Sustained response to open-label venlafaxine in drug-resistant major depression.

  Journal of clinical psychopharmacology 20010401

• Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio.

  Journal of clinical psychopharmacology 20010401

• Venlafaxine-associated mania.

  Journal of clinical psychopharmacology 20010401

• Lithium augmentation in venlafaxine-refractory depression.

  Journal of clinical psychopharmacology 20010401

• Prefrontal changes and treatment response prediction in depression.

  Seminars in clinical neuropsychiatry 20010401

• Effect of venlafaxine versus fluoxetine on metabolism of dextromethorphan, a CYP2D6 probe.

  Journal of clinical pharmacology 20010401

• Specific effect of venlafaxine on single and repetitive experimental painful stimuli in humans.

  Clinical pharmacology and therapeutics 20010401

• Sustained administration of the antidepressant venlafaxine in rats: pharmacokinetic and pharmacodynamic findings.

  Naunyn-Schmiedeberg's archives of pharmacology 20010401

• Problems with ensuring a double blind.

  The Journal of clinical psychiatry 20010401

• Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors.

  The British journal of psychiatry : the journal of mental science 20010301

• Breast cancer and hot flashes. Options for relief.

  Mayo Clinic health letter (English ed.) 20010301

• Venlafaxine occupation at the noradrenaline reuptake site: in-vivo determination in healthy volunteers.

  Journal of psychopharmacology (Oxford, England) 20010301

• Substitution of an SSRI with bupropion sustained release following SSRI-induced sexual dysfunction.

  The Journal of clinical psychiatry 20010301

• Venlafaxine withdrawal syndrome not prevented by maprotiline, but resolved by sertraline.

  The international journal of neuropsychopharmacology 20010301

• Citalopram-induced bruxism.

  The British journal of psychiatry : the journal of mental science 20010201

• Psychopharmacologic treatment of adolescent depression.

  Archives of psychiatric nursing 20010201

• Venlafaxine treatment of patients with comorbid alcohol/cocaine abuse and attention-deficit/hyperactivity disorder: a pilot study.

  Journal of clinical psychopharmacology 20010201

• Reboxetine plus citalopram for refractory depression not responding to venlafaxine: possible mechanisms.

  Psychopharmacology 20010201

• Nonaqueous capillary electrophoresis-mass spectrometry for separation of venlafaxine and its phase I metabolites.

  Electrophoresis 20010201

• Use of vancomycin silica stationary phase in packed capillary electrochromatography I. Enantiomer separation of basic compounds.

  Electrophoresis 20010201

• Fluoxetine (Sarafem) for premenstrual dysphoric disorder.

  The Medical letter on drugs and therapeutics 20010122

• Conduction disturbances associated with venlafaxine.

  Annals of internal medicine 20010116

• Effects of chronic antidepressant treatments on 5-HT and NA transporters in rat brain: an autoradiographic study.

  Neurochemistry international 20010101

• Critical use of venlafaxine serology to uncover genetic rapid metabolism.

  The Journal of neuropsychiatry and clinical neurosciences 20010101

• Evidence of early onset of antidepressant effect in randomized controlled trials.

  The Journal of clinical psychiatry 20010101

• Possible neurobiological mechanisms underlying faster onset of antidepressant action.

  The Journal of clinical psychiatry 20010101

• Pharmacology of rapid-onset antidepressant treatment strategies.

  The Journal of clinical psychiatry 20010101

• Do some antidepressants work faster than others?

  The Journal of clinical psychiatry 20010101

• Venlafaxine extended-release: a review of its use in the management of major depression.

  CNS drugs 20010101

• Even low-dose treatment of venlafaxine may provoke recurrence of hypertension in an Asian patient?

  General hospital psychiatry 20010101

• Overview of different pharmacotherapies for attaining remission in generalized anxiety disorder.

  The Journal of clinical psychiatry 20010101

• Attaining remission in generalized anxiety disorder: venlafaxine extended release comparative data.

  The Journal of clinical psychiatry 20010101

• Association study of the 5-HT(6) receptor polymorphism (C267T) and symptomatology and antidepressant response in major depressive disorders.

  Neuropsychobiology 20010101

• A multinational pharmacoeconomic evaluation of acute major depressive disorder (MDD): a comparison of cost-effectiveness between venlafaxine, SSRIs and TCAs.

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20010101

• Severe hypertriglyceridemia secondary to venlafaxine and fluoxetine.

  Psychosomatics 20010101

• The reductions in sweetened milk intake induced by interleukin-1 and endotoxin are not prevented by chronic antidepressant treatment.

  Neuroimmunomodulation 20010101

• Sertralilne, paroxetine and venlafaxine in refugee post traumatic stress disorder with depression symptoms.

  Medicinski arhiv 20010101

• Effect of halving the dose of venlafaxine to adjust for putative pharmacokinetic and pharmacodynamic changes in an animal model of chronic hepatic encephalopathy.

  Clinical neuropharmacology 20010101

• [Generalized anxiety disorders (GAD)--a neglected illness? Background und aims of the GAD-P study].

  Fortschritte der Medizin. Originalien 20010101

• [Family physician's interventions and prescribing practice. Results of the GAD-P study].

  Fortschritte der Medizin. Originalien 20010101

• An organic psychosis due to a venlafaxine-propafenone interaction.

  International journal of psychiatry in medicine 20010101

• Does combined treatment with novel antidepressants and a dopamine D3 receptor agonist reproduce cocaine discrimination in rats?

  Polish journal of pharmacology 20010101

• Pharmacokinetically induced benzodiazepine withdrawal.

  Psychopharmacology bulletin 20010101

• A pharmacokinetic drug-drug interaction study of venlafaxine and indinavir.

  Psychopharmacology bulletin 20010101

• Lethal combination of tramadol and multiple drugs affecting serotonin.

  The American journal of forensic medicine and pathology 20001201

• Seizures associated with therapeutic doses of venlafaxine and trimipramine.

  The Annals of pharmacotherapy 20001201

• Serotonergic antidepressants and urinary incontinence.

  International urogynecology journal and pelvic floor dysfunction 20001201

• The decreased in vivo clearance of CYP2D6 substrates by CYP2D6*10 might be caused not only by the low-expression but also by low affinity of CYP2D6.

  Archives of biochemistry and biophysics 20000815

• The impact of the CYP2D6 and CYP2C19 genotypes on venlafaxine pharmacokinetics in a Japanese population.

  European journal of clinical pharmacology 20000501

• Benztropine for venlafaxine-induced night sweats.

  Journal of clinical psychopharmacology 20000401

• Venlafaxine serum levels and CYP2D6 genotype.

  Therapeutic drug monitoring 20000401

• Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine.

  The Journal of clinical psychiatry 20000401

• Venlafaxine-associated hepatitis.

  Annals of internal medicine 20000307

• [Venlafaxine withdrawal syndrome: report of six cases and review of the literature].

  La Revue de medecine interne 20000301

• Depression induced by orlistat (Xenical).

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20000201

• Venlafaxine treatment of cocaine abusers with depressive disorders.

  The American journal of drug and alcohol abuse 20000201

• Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group.

  The Journal of clinical psychiatry 20000201

• Neuroleptic malignant syndrome after venlafaxine.

  Lancet (London, England) 20000122

• Antidepressants upregulate messenger RNA levels of the neuroprotective enzyme superoxide dismutase (SOD1).

  Journal of psychiatry & neuroscience : JPN 20000101

• Antidepressant efficacy of venlafaxine.

  Depression and anxiety 20000101

• Clozapine-induced acute interstitial nephritis.

  Lancet (London, England) 19991002

• Dystonia as a side effect of nonneuroleptics.

  Journal of the American Academy of Child and Adolescent Psychiatry 19990701

• Venlafaxine-associated hepatitis.

  Annals of internal medicine 19990601

• Extrapyramidal symptoms associated with the adjunct of nortriptyline to a venlafaxine-valproic acid combination.

  International clinical psychopharmacology 19990501

• Altered open-field behavior in experimental chronic hepatic encephalopathy after single venlafaxine and citalopram challenges.

  Psychopharmacology 19990401

• Mirtazapine: clinical overview.

  The Journal of clinical psychiatry 19990101

• Serotonin syndrome induced by transitioning from phenelzine to venlafaxine: four patient reports.

  Neurology 19980701

• Serotonin syndrome secondary to phenelzine-venlafaxine interaction.

  Pharmacotherapy 19980101

• Pharmacological profile of venlafaxine, a new antidepressant, given acutely.

  Polish journal of pharmacology 19980101

• A case of serotonin syndrome caused by venlafaxine and lithium.

  Pharmacopsychiatry 19971101

• Withdrawal syndrome after discontinuation of venlafaxine.

  The American journal of psychiatry 19971001

• Syndrome of inappropriate ADH secretion attributed to the serotonin re-uptake inhibitors, venlafaxine and paroxetine.

  The Netherlands journal of medicine 19970601

• Venlafaxine, monoamine oxidase inhibitors, and the serotonin syndrome.

  Journal of clinical psychopharmacology 19970201

• Seizure resulting from a venlafaxine overdose.

  The Annals of pharmacotherapy 19970201

• Urinary retention with venlafaxine-haloperidol combination.

  Pharmacopsychiatry 19970101

• Bupropion plasma levels and CYP2D6 phenotype.

  Therapeutic drug monitoring 19961001

• Serotonin syndrome from venlafaxine-tranylcypromine interaction.

  Veterinary and human toxicology 19961001

• Venlafaxine.

  Nursing 19960301

• Serotonin syndrome induced by administration of venlafaxine and phenelzine.

  The Annals of pharmacotherapy 19960101

• Toxic interaction of venlafaxine and isocarboxazide.

  Lancet (London, England) 19951111

• Phenelzine and venlafaxine interaction.

  The American journal of psychiatry 19950901